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ABSTRACT
Multiple research problems related to the lung involve a need to take into account
the spatiotemporal dynamics of the underlying component cells. Two such problems
involve better understanding the nature of the allergic inflammatory response to explore
what might cause chronic inflammatory diseases such as asthma, and determining the
rules underlying stem cells used to engraft decellularized lung scaffolds in the hopes of
growing new lungs for transplantation. For both problems, we model the systems
computationally using agent-based modeling, a tool that enables us to capture these
spatiotemporal dynamics by modeling any biological system as a collection of agents
(cells) interacting with each other and within their environment. This allows to test the
most important pieces of biological systems together rather than in isolation, and thus
rapidly derive biological insights from resulting complex behavior that could not have
been predicted beforehand, which we can then use to guide wet lab experimentation.
For the allergic response, we hypothesized that stimulation of the allergic
response with antigen results in a response with formal similarity to a muscle twitch or an
action potential, with an inflammatory phase followed by a resolution phase that returns
the system to baseline. We prepared an agent-based model (ABM) of the allergic
inflammatory response and determined that antigen stimulation indeed results in a twitchlike response. To determine what might cause chronic inflammatory diseases where the
twitch presumably cannot resolve back to baseline, we then tested multiple potential
defects to the model. We observed that while most of these potential changes lessen the
magnitude of the response but do not affect its overall behavior, extending the lifespan of
activated pro-inflammatory cells such as neutrophils and eosinophil results in a prolonged
inflammatory response that does not resolve to baseline. Finally, we performed a series of
experiments involving continual antigen stimulation in mice, determining that there is
evidence in the cytokine, cellular and physiologic (mechanical) response consistent with
our hypothesis of a finite twitch and an associated refractory period.
For stem cells, we made a 3-D ABM of a decellularized scaffold section seeded
with a generic stem cell type. We then programmed in different sets of rules that could
conceivably underlie the cell’s behavior, and observed the change in engraftment patterns
in the scaffold over selected timepoints. We compared the change in those patterns
against the change in experimental scaffold images seeded with C10 epithelial cells and
mesenchymal stem cells, two cell types whose behaviors are not well understood, in
order to determine which rulesets more closely match each cell type. Our model indicates
that C10s are more likely to survive on regions of higher substrate while MSCs are more
likely to proliferate on regions of higher substrate.
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CHAPTER 1: INTRODUCTION
A variety of seemingly dissimilar research problems related to the lung have, at their
core, a need to take into account the underlying dynamics of the involved cells over both
space and time.
One such problem deals with the failure in generating ovalbumin (OVA) mouse
models of chronic asthma. Many individuals have severe, continual asthma attacks that
can be fatal, which according to current theory is most often due to an allergic response
triggered by the presence of inhaled antigen. Researchers have attempted to create animal
models of chronic asthma by sensitizing and subsequently challenging mice repeatedly
with OVA protein as an allergen. Unlike what occurs in chronic asthma, however, the
mice eventually stop responding to OVA and return to baseline—a phenomenon known
as tolerance. However, if they are challenged again after a month, the mice now undergo
a vigorous allergic response. This leads us to suggest a novel hypothesis for the allergic
inflammatory response in the lung, which we term the inflammatory twitch. It states that
the normal allergic response is a sequence of events that leads to both inflammation and
its subsequent resolution, with the implication that chronic inflammatory conditions such
as asthma involve a defect that prevents resolution to baseline. This raises the questions
of whether the behaviors of the cells involved in the normal allergic response could result
in a twitch-like response, and if so, what abnormalities in the response would result in a
non-resolving twitch.
Studying issues of lung function leads naturally to questions about how the lung is
formed in the first place. We focus on the research problem of how to generate new lungs
1

from old lungs that have been stripped of their cellular material, leaving behind a protein
scaffold that can be subsequently seeded with stem cells in the hopes of growing a new
organ. This could eventually enable growth of a new organ specific to an individual’s
immune system using their own stem cells. However, current efforts in this direction
have been mostly exploratory, with little to no formal understanding of the rules of
behavior for the utilized cells.
To make headway on both these research questions requires a firm understanding of
the spatiotemporal dynamics of the cells and environments. In the case of the allergic
response, we must determine the most important behaviors of the cells involved, as well
as how they affect and are affected by their local environment. For stem cells, we must
critically test hypotheses regarding how the cells could engraft and proliferate on the
scaffold and how the cells and the scaffold could interact and affect each other. In both
instances, it would be difficult, if not impossible, to take all these interactions into
account to make mental predictions of the response over a long period of time.
Furthermore, addressing all these issues experimentally would be challenging and require
a great deal of time and effort.
However, computational modeling enables us to rapidly vet potential hypotheses
regarding the behavior of all the components of biological systems, and can thus serve as
a useful adjunct to experimental work to guide our understanding of these systems.
Computational modeling is widely used throughout science for understanding complex
phenomena and for predictive purposes, and is gaining increasing acceptance in
medicine. In this dissertation we examine the use of a specific form of computational
2

modeling known as agent-based modeling to address questions related to the
spatiotemporal dynamics of cells in the lungs. Agent-based models have been widely
used for several decades and have recently gained greater interest due to increased
available computational power that enables more rapid simulation.
In Chapter 2, we present a comprehensive literature review of computational
modeling, with an emphasis on agent-based modeling and its potential usefulness in the
biomedical realm.
In Chapter 3, we present an agent-based model of the allergic inflammatory response
to determine if twitch-like behavior can emerge from the major cell-cell and cellenvironment interactions, which was published in the Journal of Immunology (Pothen,
J.J., Poynter, M.E., Bates, J.H.. (2013). The Inflammatory Twitch as a General Strategy
for Controlling the Host Response. Journal of Immunology, 190(7):3510-6.).
Chapter 4 shows how we use this model to test a range of potential defects to the
twitch mechanism to determine which (if any) prevent its resolution to baseline, which
was published in the American Journal of Physiology Lung Cellular and Molecular
Physiology (Pothen, J.J., Poynter, M.E., Bates, J.H.. (2015). A Computational Model of
Unresolved Allergic Inflammation in Chronic Asthma. American Journal of Physiology
Lung Cellular and Molecular Physiology, 308(4):L384-90).
In Chapter 5, we then critically test the twitch hypothesis’s implications of the twitch
duration and the refractory period in OVA mouse models (submitted for publication:
Pothen, J.J., Poynter, M.E., Lundblad, L.K., Bates, J.H.. Dissecting the inflammatory
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twitch in allergically inflamed mice. American Journal of Physiology Lung Cellular and
Molecular Physiology.).
In Chapter 6, we use agent-based modeling to model the behavior of stem cells on
decellularized lung scaffolds in order to determine the potential rules underlying the
cellular behaviors (submitted for publication: Pothen, J.J., Rajendran, V., Wagner, D.,
Weiss, D.J., Smith, B.J., Ma, B., Bates, J.H.. A Computational Model of Cellular
Engraftment on Lung Scaffolds. Tissue Engineering.)
Chapter 7 closes with a summary of the major findings and future directions for the
work featured in this dissertation.
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CHAPTER 2: REVIEW OF BIOMEDICAL COMPUTATIONAL MODELS
2.1 Introduction
Investigation into clinical issues often begins with in vitro laboratory work,
followed by in vivo investigation in established animal models and eventual clinical
testing [1]. However, initial inquiries in the laboratory often require extensive amounts of
both time and costly experimental resources. A more rapid, effective means of vetting
proposed hypotheses to determine the most promising to pursue at the experimental stage
could thus greatly accelerate the advancement of biomedical knowledge.
To this end, we endorse computational modeling as an alternate, complementary
means of studying biological systems. While it cannot replace experimental inquiry due
to the complexities of in vivo biological systems, computational modeling can serve a
useful adjunct, particularly at the initial stages of investigation. In silico models provide a
rapid, cost-effective way to test the feasibility of potential hypotheses regarding a
biological system, thereby facilitating experimental pursuit of hypotheses with increased
likelihood of success. These models represent our understanding of the most important
features of a biological system. If the model fails to behave like the system under study,
then it indicates that there is at least one other important feature missing in the model,
and thus from our understanding. The model can then serve as a virtual laboratory for the
investigation of what these missing factors might be.

2.2 Forms Of Computational Models
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Here we highlight some of the more common forms of computational modeling
encountered in biological studies.
One means of computationally representing a biological system is via a system of
mathematical equations, often ordinary or partial differential equations (ODEs or PDEs,
respectively). Such models have been used, for example, to model the normal and
diabetic response in the glucose-insulin regulatory system [2-8], the MAPK/ERK
pathway implicated in many forms of cancer [9-11], the β-adrenergic and
NO/cGMP/PKG pathways in cardiac cells [12-13], the hemodynamic response to
occlusion of blood vessels [14-15], and the number of cells in each stage of the
differentiation process for adipose cells [16] and hematopoietic stem cells [17-20].
Differential equations are by their nature continuous, and assume that the
variables involved are continuous in nature. Therefore they cannot capture discrete
events, such as variables that undergo a discontinuous transition between different values
such as from zero to non-zero (which may serve as a transition from an off state to an on
state), or discrete agents in the model that alter their behavior over the course of the
simulation. These equations often involve multiple parameters that must be determined
by fitting the equations to an existing dataset. Thus to effectively utilize this form of
modeling also requires some foreknowledge of the quantitative behavior of the
phenomenon being studied, which can be problematic in cases where continual
experimental measurement of the phenomenon is difficult or impossible to perform.
Furthermore, ODE equations capture change in a system with respect to a single variable,
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often time. PDEs can determine the change in a system with respect to multiple variables,
such as both time and space, but are more difficult to solve.
However, systems of differential equations can be discretized, as in a form of
modeling known as finite element modeling, which is often used to represent systems in
which spatial details are important. Here a geometric surface of interest is broken down
into simpler individual elements, each of which has mathematical equations governing its
behavior. Combining these elements computationally thus enables prediction of the entire
structure’s behavior. Some examples of biomedical research questions studied using
FEM include repair of bone fractures [21-22]; mechanical behavior of normal and
abnormal aortic valves [23-35], along with those valves following surgical interventions
in the aorta [36-44]; the change in forces and movement of the bone, ligament, muscle
and cartilage components of the knee joint in response to normal movement [45-58] and
in response to osteoarthritis [59-63], the flow of lymph fluid across lymphatic valves [6465], and the effects of deep brain stimulation therapy on electrical activity in various
brain structures [66-69]. In all of these, FEM is an intuitive modeling form because of the
emphasis on the geometry and known mechanical or physical behavior.
Another discretized mode of modeling is the cellular automaton (CA) [70]. Here,
a system is modeled as a grid of stationary “cells”, each of which has a state. Each cell’s
state during a timepoint in the simulation is determined by the state of that cell and
others, often neighboring cells. Thus it is intuitive that CA modeling can simulate the
growth or spread of a pattern throughout an environment. There are many published CA
7

models that study, for example, the behavior of tumor cells such as their growth and
apoptosis [71-80], genetic evolution [81-87], and their eventual metastasis throughout an
environment [87-89]. Other examples of CA models include the spread of HIV-1
throughout lymphoid tissue [90], simulation of pressure in uterine cells during pregnancy
contractions [91] and electrical wave propagation in both cardiac [92] and intestinal cells
[93-95]. In these models, the cells involved are often stationary. It is possible to model
motile elements such as cells that traverse the environment in CAs, though it is less
intuitive relative to other methods.
2.3 Overview Of Agent-Based Modeling
For the remainder of this review, we concern ourselves with agent-based
modeling. While there are other ways of defining an agent-based model (ABM), we use
the definition in which an ABM is a discretized model in which a group of agents interact
over space and time within an environment according to user-set rules [96-98]. This
environment can be modeled either continuous (real space) or discrete (e.g. a 16 x 16 tile
grid), and can be tailored to represent a variety of 2-D or 3-D structures. Agents, as
indicated by their name, are distinct from the environment and can affect both the
environment and other agents over the timecourse of the simulation. They can represent a
variety of objects, such as molecules, cells, tissues, or organs. Each agent has a local
neighborhood defining the subset of the environment and agents that it can interact with
at a particular instant in time. To determine the state of the agents at a particular
timepoint, the rules are applied to each agent in the model at the previous instant in time.
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The flexibility in the design of ABM’s enables us to easily represent and
investigate the spatiotemporal dynamics of a variety of biological systems at many scales.
Modeling multiple pieces of a biological system simultaneously allows for cross-talk
between different types of interactions such as cell-cell or cell-environment (as defined
by the model rules). Even when these interactions are simple, they can lead to emergent
behavior—phenomena with complex behavior that could not have been easily predicted
beforehand. This is particularly advantageous, as it means that the precise quantitative
behavior of the system does not need to be known beforehand but arises naturally out of
the interactions inherent in the model.
It should be noted that ABMs can have formal similarity to other forms of
modeling. For instance, a CA model can be thought of as a type of ABM. However,
ABMs are perhaps the most intuitive form of computational modeling for any biological
system. This enables easier comprehension of the model’s formal construction across
multiple research disciplines.
Interestingly, many of the earliest ABM’s were developed in the realm of social
science. In 1971, Thomas Schelling proposed a model of segregation in which agents
within a two-dimensional environment can move and dynamically self-segregate based
on rules determining each agent’s preferences regarding neighbors and space [99]. Since
then, ABM’s have been utilized by many social science fields, including psychology,
economics, law and anthropology [100]. Questions addressed by many of these models
include decision-making as it pertains to individuals, groups and markets [101-115],
9

dissemination of ideas and resources across groups and societies [116-136], the use and
change in land and urban areas [106-108, 137-157], the formation and dynamics of social
networks in groups and societies [158-178], and understanding and predicting the
outbreak of sociopolitical change and conflict within a region [179-196].

2.4 Agent-Based Models In Biomedical Research
In the field of biology, ABM’s have been used to model such phenomena as
animal behavior [197-217], the epidemiology and transmission dynamics of infectious
diseases [218-237], and the pathogenesis, growth and metastasis of tumors [238-255]. To
illustrate the numerous possibilities for ABM’s to elucidate human disease, we discuss
seven recently published biomedical ABM’s. These include models of breast cancer, the
immune system, melanoma, pressure ulcer formation, embryonic vasculogenesis, muscle
atrophy and lung inflammation. Together, these models demonstrate the breadth and
depth of systems that can be rapidly investigated using this form of computational
modeling.
In the subsequent sections, we discuss the biomedical question each ABM was
designed to answer and explain the authors’ reasoning for utilizing a computational
approach. We provide a brief overview of the key features of each model, with an
emphasis on how the agents, environments and rules were chosen and calibrated. We
then show and discuss results generated from the model, with an emphasis on emergent
phenomena and insights into the biological systems that can be used to generate
hypotheses for future wet lab experimentation.
10

2.4.1. Breast Cancer
The first model we examine is an ABM of the pathogenesis of breast cancer in
ductal epithelium [256]. This model examines how different combinations of genetic
events accumulate over time, resulting in sequences of events that can transform normal
mammary cells into tumors that do or do not express estrogen receptors. The
classification of tumors into ER+ and ER- types, respectively, is a classical method for
studying breast tumors and determines appropriate medication regimens.
The impetus for creating a computational model to explore the pathogenesis was
the inherent difficulty in utilizing a detailed experimental investigation. Longitudinal
study of the breast epithelium’s transformation into the early tumor is difficult if not
impossible, as the timescale over which the mutations accumulate and result in cancer is
both long and highly variable. The mutations associated with breast cancer are also rare,
making it difficult to identify how combinations of these genetic changes affect the
normal function of the epithelium prior to detection of the tumor, by which point the
tumor has already grown to a considerable size. The complex nature of the cellular
environment further complicates this analysis, as it contains both activating pathways that
lead to tumor formation, along with inactivating pathways and means of compensating
for molecular changes.
This led the researchers to develop an ABM where the environment is a 2dimensional section of bilayered mammary epithelium, indicative of a mammary duct
that has been cut open and laid flat. The agents are the cell types selected by the
11

researchers as the most importance to maintenance of the ductal epithelium: luminal and
myoepithelial cells, stem and progenitor cells, and fibroblasts. While the model is
presented in extensive detail in the paper, we summarize its major features here.
Myoepthelial cells and their progenitor cells have a neighborhood defined by the

Figure 1: Set of genes and the rules underlying their direct effects on cellular behavior and the
environment in the ductal epithelial ABM. Modified from [254]
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surrounding patches, i.e. if they are in the center tile of a 3x3 tile grid, their neighbors are
the eight surrounding tiles. Other cells tend to consider the grid patch they are currently
on or the patch directly ahead. Each cell is represented as having both DNA and cellular
receptors, and thus has variables representing receptors, signaling molecules (e.g.
hormones), genes, gene transcription factors and DNA lesions. Furthermore, the cells
have DNA repair mechanisms that can fix damage to the genes. The cells in the model
undergo division and apoptosis, and can pass on subsequently damaged or mutated DNA
to cells, allowing mutations to accumulate over time. While cells have two copies of each
gene, one functional copy of the gene enables the cell to maintain that gene’s function.
The rules for this model, summarized briefly in Figure 1, dictate the effects of the

Figure 2: (A) Cumulative cancer incidences, reported as percentages of all individuals, from SEER
2010 review data and the ductal epithelial ABM, for individuals with and without BRCA1-mutations
(simulated as in the ABM as a loss-of-function). For the computational model, these percentages were
reported after 15000 steps or ~40 simulated years, with the average result of 3 subgroups, each with
500 simulations. (B) Longitudinal cancer incidences between ages 30 and 55 as reported in 3 separate
runs of the ABM (with 500 simulations for each run) and from previously published studies (with
each one labeled by author name). Modified from [254]
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expressed genes on the cell, such as expression of hormone receptors, damage
management, space constraints and growth regulation of the cell. The model was
calibrated so that 1 time step is the equivalent of 1 day, and then run for the equivalent of
15,000 days (about 40 years).
The ABM enabled the researchers to determine factors missing from their
understanding of tumorigenesis. Given the impossibility of accounting for every gene
related to the mammary duct, the model initially contained a minimal set of 7 genes
known to be critical in tumor development. However, this version of the model only
yielded ER- tumors, which they determined was a result of ER+ cells being unable to
divide. They then searched for a gene that could modulate ER+ cell proliferation, which
led them to the gene RUNX3. Once this was included in the gene set, the ABM yielded
outputs for the cumulative cancer index for both BRCA and non-BRCA mutated tumors
(Figure 2) that were consistent with previously reported experimental measures, both for
tumors with a mutated, nonfunctional BRCA gene and for tumors where this gene was
unperturbed. The percentage of ER+ tumors for both BRCA and non-BRCA mutated
tumors were also consistent with percentages previously reported in longitudinal studies,
as seen in Figure 3.
As RUNX3 had not previously been considered a potential player in ER+
tumorigenesis, the researchers investigated this gene using data from two databases of
cancer transcriptomes, and confirmed that loss of RUNX3 was correlated to ER+ status in
formation of ER+ tumors. The ABM simulations indicate that loss of RUNX3 results in
14

Figure 3: Percentage of ER+ tumors with a BRCA mutation, from literature studies (shaded in gray,
labeled by author name) and from 3 separate runs of the ductal epithelial ABM (shaded in red, each
with 500 simulations). Modified from [254]

Figure 4: RUNX3 expression for ER- and ER+ individuals utilizing data from the Cancer Genome
Atlas and Oncomine, expressed as log2 median-centered ratios. Modified from [254]
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breast tumors (Figure 4). This raised the question as to how RUNX3’s loss affects the
ER+ luminal cell expression of c-Met, and allows ER+ cells to receive proliferative
stimuli via HGF signaling. Thus the ABM provided a novel hypothesis about a critical
gene involved in ER+ tumorigenesis and its role in tumor formation, which can now be
tested experimentally.
2.4.2. Human Immune System
We now turn our attention to a 3-dimensional ABM that studies the decentralized
processes in the human immune response to viral infection [257]. This response
incorporates humoral and cell-mediated immunities in both lung and lymph node regions
of the human body.
The model was developed due to the difficulty in utilizing a purely experimental
approach to study immune processes in multiple regions of the body, specifically cellular
movement and interactions throughout the entire timecourse of the response. Even in
isolated regions the immune processes are inherently complex, involving so many cells
and signals that measuring all the interactions at each moment in time would require great
effort. Furthermore, responses such as the host immunity to pathogens are known to be
complex emergent phenomena, and thus unable to be predicted mentally due to the sheer
number of components and the associated behaviors.
This led the researchers to create a multiscale 3D ABM of the immune system as
seen in the lung and a regional lymph node, incorporating modeling at the sub-cellular,
16

cell, tissue and organ scales. The individual agents are epithelial cells, viruses and the
immune cells involved in the humoral and/or cell-mediated responses (namely
macrophages, dendritic cells, B cells, T cells and antibodies), as shown in Figure 5. In the
model, each agent has an attraction sphere centered around it, enabling two agents to
interact if one of them enters the attraction sphere of the other. This defines the
neighborhood over which agents can interact. Figure 6 shows the set of interactions in the
model and how they change the states of the cellular agents. The lung region of the model
is created as an environment of 200 epithelial cells that are initially placed in the model,
after which they can reproduce and arrange themselves depending on their interactions.
The lung also contains immature dendritic cells that, upon activation with viral particles,
can migrate to the lymph node region of the model, which contains B and T cells. These
can both become specific to the virus in order to help clear it from the model, as well as
undergo proliferation or apoptosis. Cell migration between the two regions is modeled by
having the lung and lymph node environments exchange the total number of agents
within them along with the current environmental state at each timepoint. The agents in
these compartments then use the latter information to update their behavior accordingly.
The ABM was run for 20 simulations with each simulation taking 6000 time steps,
calibrated to be the equivalent of 30 days.

Figure 5: List of agents utilized in the immune system ABM (not drawn to scale): a) antibody, b)
virus, c) epithelial cell, d) B cell, e) T cell, f) macrophage and g) dendritic cell. Modified from [255]
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Using this model, the researchers could visualize the spread of infection with
virus (in this case, influenza A) through the lung and lymph nodes and determine the
extent of immune system activation by measuring viral load and the number of each cell
type over time. Figure 7 shows a graphical representation of the change in the lung
epithelium in response to viral infection, as well as the proliferation of B and T cells in
the lymph node. Importantly, the researchers found that viral loads did not result in a
hyperactive immune system or in complete tissue destruction, but yielded results
consistent with what was predicted by another robust mathematical model of the spread
of influenza A infection.
The ABM also enables prediction of the immune system’s adaptive capabilities,

Figure 6: Schematic illustrating the rules governing agent interactions in the immune system ABM.
Different colors indicate different types of interactions. Modified from [255]
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Figure 7: Images of the immune system ABM’s tissue (left) and lymph node (right) environments
over time in response to influenza infection. Blue and green spherical cells represent healthy cells,
while red cells indicate infected cells. Modified from [255]
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measured here by how the system responds to a second viral exposure. They observed a
distinctive response relative to the response triggered by the first exposure, as shown in
Figure 8, with significantly less damage and a lower maximal viral load. The cellmediated reactions also started earlier and were significantly less intense, and the overall
timecourse of the adaptive response is consistent with what has been reported in multiple
immunology textbooks. While these are preliminary results, they nevertheless illustrate
how complex immune processes can be visualized and studied over time across multiple
organs and regions.

Figure 8: Number of agents over the timecourse of the immune system ABM simulation, with
reintroduction of the virus at time step 8000. Modified from [255]
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2.4.3. Melanoma
We now examine an ABM of melanoma behavior and associated angiogenesis
[258]. Melanoma is the most malignant type of skin cancer, responsible for 3/4 of all
skin-cancer-related deaths. While there is interest in a chemotherapy treatment, there
have been drastic differences between in vitro and in vivo success of drugs due to issues
in absorption, distribution, metabolism and toxicity.
To address this, the researchers focused on the effects of different drugs on both
the behavior of melanoma cells and the development of new capillary sprouts. They
focused on the latter factor, though less intuitive, because angiogenesis enables more
nutrients and oxygen to be brought to the tumor and thus is significant in its growth and
survival, and because the shape of a tumor’s underlying vasculature affects the
distribution of the drug. To more fully understand these effects, they wanted to observe
the effects at multiple scales: intracellular, intercellular and tissue. Given the difficulty of
generating an experimental protocol that would allow observation of each scale at every
instant in time, they developed a 3D ABM containing these three scales, which they
noted was the first of its kind at the time of publication.
In this model, the agents are melanoma and endothelial cells, which can both exist
in active (migratory or proliferative), dead (apoptotic) or quiescent phenotypic states.
Both can grow into tumor and vasculature, respectively, within a 3D cube environment
that simulates a slice of tumor extracellular matrix (ECM). The model is initialized with
100 active melanoma cells distributed as a sphere in the center of the cube, along with 16
21

Figure 9: Schematic showing the states and behavioral rules for tumor cells (top) and endothelial
cells (bottom) in the melanoma ABM. Modified from [256]
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endothelial cells distributed on the surface of the ECM. VEGF and glucose are required
for growth, and are normally distributed throughout the cube when the model is
initialized. The vasculature can also deliver oxygen, cytokines and glucose to the tumor’s
melanoma cells, which may undergo phenotypic switching in response to the cytokines,
and which can secrete VEGF once there is a drop in glucose and oxygen. A drop in the
latter induces blood vessel sprouts to branch outward. A graphical layout of the rules for
the tumor and endothelial cells in the model is shown in Figure 9. Equations regulating
apoptosis follow an exponential distribution, while the levels of glucose, VEGF, or drugs
at any location and moment in time follow a recursive function dependent on the levels at
that location and on its six neighbors (Von Neumann neighbors) at the previous instance
in time.

Figure 10: 3D images of the melanoma ABM at different timepoints, indicating the tumor (central
mass) and associated vasculature composed of endothelial cells (colored in red). The tumor is
composed of cells that are quiescent (blue), active (yellow), or dead (gray). Modified from [256]
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Figure 11: For the melanoma ABM, a) Total number of cells following no drug (control),
doxorubicin, sunitinib or both doxorubicin and sunitinib over the timecourse of the simulation. b)
Number of active cells under the different drug treatments over the timecourse of the simulation.
Modified from [256]
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The model also tests two drugs: doxorubicin, an anti-tumor drug that increases the
rate of apoptosis by directly incrementing appropriate model parameters, and sunitinib,
an anti-angiogenesis drug that prevents endothelial cell receptors from receiving the
VEGF produced by fast growing melanoma cells, thereby increasing the rate of apoptosis
of the endothelial cell tip. The researchers investigated the effects of these two drugs both
alone and in combination to determine the most efficacious treatments for inducing
melanoma apoptosis. Each experiment in the model was performed 20 times and was run
for 200 time steps, calibrated to be the equivalent of 400 hours.
Using the model, the researchers generated hypotheses regarding the behavior of
the individual cells and the tumor. For instance, they observed that near blood vessels,
quiescent tumor cells often switch to a migratory or proliferative mode. They also
compared the 3-D volume of the tumor over the timecourse of the simulation against
experimental measurements of tumor growth to illustrate a comparable growth curve.
Figure 10 shows representative images of the tumor at various timepoints in the
simulation. Using these, they determined the appearance of the surrounding vasculature
and the states of all the cells in the model over time. Utilizing the angiogenesis-targeted
sunitinib was significantly more effective than the anti-tumor drug Doxorubicin at
decreasing the size of the tumor. However, the two drugs in combination had a
synergistic effect that both increased the rate of apoptosis and decreased the amount of
nutrients delivered to the tumor (Figure 11). The researchers used a sensitivity analysis of
the model parameters to confirm a high correlation between blood delivery rates of
nutrients and drugs and the outcome of regression and death of the tumor. This suggests
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these two drugs may serve as an effective treatment for melanoma, and can now be
evaluated experimentally for their efficacy.
2.4.4. Pressure Ulcer Formation
The next ABM we consider studied the dynamics of skin blood flow and pressure
ulcer formation [259]. The underlying motivation is care of patients with spinal cord
injury (SCI), for whom total cost of care in the United States alone amounts to $7 billion
each year. In this population, there is a high prevalence of pressure ulcers due to multiple
factors such as impaired mobility, sensation and vascularization. Of the potential
pathways, the researchers identify pressure-induced tissue ischemia as the most important
in determining formation of the ulcer. Interestingly, tissue ischemia paradoxically leads
to an increase in skin blood flow, a phenomenon known as ischemia-induced hyperemia.
Yet as the ischemia is prolonged, it ultimately results in local inflammation and the
necrosis that forms the ulcer. The researchers wanted to use this known biological
behavior to develop a tool that could directly improve patient care. In particular, they
were interested in determining how often bedridden SCI patients must be turned to
prevent ulcer formation. Computational modeling was thus appealing to them since it
provided a rapid means of performing turning studies that could not be easily performed
in human subjects.
The researchers had previously determined a set of differential equations
governing blood flow in skin, but this lacked information regarding the epithelial spatial
features over the timecourse of the ischemic response. Thus they incorporated these
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equations as rules regarding blood flow into an ABM of a tissue region that incorporated
multiple biological insights regarding skin injury, inflammation and healing. While this
ABM is necessarily a simplified version of the in vivo system, it nevertheless contains
what they determined to be the most important features of the environment and the agent
behavior, thus enabling them to capture both local and global features involved in the
response to ischemia. Furthermore, this model has a degree of complexity that makes its
predictions only realizable through computer implementation.
In this ABM, the environment is a 2D segment of tissue composed of square
epithelial cells, with blood vessels distributed in a uniform grid pattern. Epithelial cells
can be damaged both by pressure and by chemical signals, and have an individual life
value initialized at the maximum value of 100. If the cell’s life value ever drops to 0, it
dies. If its life drops below a critical value (set at 80), the epithelial cell will release TNF
(a coarse-grained version of all pro-inflammatory cytokines) into the environment. The
surrounding vessels release oxygen (which diffuses into the eight surrounding patches)
and can bring macrophages into the environment. Macrophages are chemoattracted by
TNF or else will traverse the environment randomly. These cells can release either TNF
or TGF-β (a coarse-grained version of all anti-inflammatory and pro-healing cytokines),
which directly damage or repair epithelial cells, respectively. In considering where to
move, a macrophage considers three potential locations in the vector of its current
direction: directly ahead, ahead and to the left, or ahead and to the right. The rules
governing blood flow, and thus the supply of oxygen and macrophages, are governed by
the previously determined ordinary differential equation (ODE) system, which receives
27

Figure 12: A) shows the main components and interactions in the pressure ulcer ABM (with Mac
indicating macrophages, representative of inflammatory cells). B) shows the ODE system is
connected to the ABM. Modified from [257]
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the ABM’s frequency of the applied pressure as an input. We show a diagram
summarizing the model setup and the underlying rules in Figure 12. The model was then
calibrated using blood flow data for patients with and without SCI, with the latter group
functioning as a control. Following calibration of the model parameters for each patient,
the researchers then applied different pressure intervals to the model over a timecourse of
2000 time steps.
Simulated SCI patients had substantial death of multiple epithelial cells at lower
pressure intervals relative to control patients, as seen in Figure 13. The researchers then
tested different turning frequencies for both the SCI and control models, and then tested
different turning frequencies in SCI and non-SCI patients, as shown in Figure 14. In both
groups, turning every 80 time steps resulted in a stable pattern in the overall health of the
epithelial tissue, whereas waiting longer periods of time to turn resulted in a substantial

Figure 13: Image of the pressure ulcer ABM after 2000 time steps for A) the control group with a
pressure interval of 210 time steps, and B) the spinal cord injury (SCI) group with a pressure
interval of 107 time steps. Here, green squares represent healthy epithelial cells, while red squares
represent damaged epithelial cells and white squares represent dead cells. Red circles represent
blood vessels, and blue circles represent macrophages. Modified from [257]
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decrease in the tissue’s health, implying a higher likelihood of ulceration. As the
timescale of this model is arbitrary, further work must be done to calibrate it to determine
clinically appropriate turning frequencies. Nevertheless, it represents a first step in
moving towards an ABM that can improve individual patient care.
2.4.5. Blood Vessel Development
The next agent-based model we consider simulated vascular development and
disruption during embryogenesis [260]. Its focus is on microenvironmental cues and

Figure 14: Average tissue health, which decreases as epithelial cells undergo apoptosis, over the
timecourse of the simulation of the pressure ulcer ABM for different pressure intervals` for A)
control group and B) spinal cord injury (SCI) group. Each group is averaged using the outputs from
the model’s outputs for six different individuals. Modified from [257]
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events that promote or disrupt the growth of capillary plexi. The researchers note that the
events involved in the embryo vasculogenesis are similar to those involved in
pathological vessel growth, meaning such modeling efforts could ultimately have
applications in wound healing and tumor angiogenesis, for instance.
Agent-based modeling was advantageous in this study because of the complexity
of the processes involved. Predicting embryonic behavior requires accounting for a large
amount of biological data regarding complex cell-cell and cell-environment interactions
across multiple biological pathways, as well as the coordinated regulation of cellular
behavior such as mitosis, migration, contractility and extracellular matrix (ECM)
remodeling. Thus the researchers argued that a thorough understanding necessitated a
multiscale modeling approach that incorporated this knowledge to allow for the
possibility of emergent behavior, which can then be evaluated for biological insight.
Furthermore, by developing a model that can simulate normal growth, the researchers
could then simulate the effects of different chemicals to determine if they disrupt normal
vessel growth, and if so, how. This ultimately could help them further determine the most
critical events in normal capillary formation.
To do this, the investigators developed a 2D cellular ABM that simulates lateral
splanchnic mesoderm as a flat plane upon which developing vessels can grow. The agents
in this model are inflammatory cells (ICs), apoptotic cells, mural cells (MCs),
endothelial-tip cells (EC-tip) and endothelial-stalk (EC-stalk) cells. In order to both
determine the major cellular signals and parameterize the model appropriately, they
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constructed an e-library to retrieve relevant articles on embryonic and fetal blood growth
and development. They then selected 12 chemical signals that influence cellular behavior
either alone or in combination. Seven of these are represented as biochemical fields with
diffusion equations, while the other five are represented by their effects on cellular
behaviors (e.g. engraftment, motility). The rules governing these signals’ effects on the
cellular behaviors are shown in Figure 15. The physical features of cells (e.g. cellular
volume) and their behaviors (e.g. chemotaxis) are modeled as a system of equations
utilizing the features of surrounding cells.

Figure 15: List of all cell types, along with their associated behaviors and signals in the
vasculogenesis ABM. Modified from [258]

32

From the model, they observed that capillary networks indeed emerge as a result
of environmental cues and cellular behavior. As shown in Figure 16, an initial network
forms as a result of EC-tip cellular exploration of the local environment, which is then
followed behind by EC-stalk cells that subsequently proliferate. The network
subsequently grows and reaches a steady state in which the total number of cells remains
the same while the network nevertheless continues to grow and remodel, leading to
increased vessel thickness and proliferation stabilized by surrounding MCs. This activity
results in part via bridging of the EC-tip cells, a consequence of both signal concentration
fields and cellular adhesions.
The researchers then used the ABM to explore how vasculogenesis is disrupted by

Figure 16: Snapshots of the control-calibrated vasculogenesis ABM at six different timepoints over
10,000 time steps (or 3 computational hours). Red cells represent endothelial cells, green cells
represent mural cells, and inflammatory cells represent yellow cells. Modified from [258]
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5HPP-33, a reference molecule known to be anti-angiogenic. They determined several
molecular effects of 5HPP-33 using a high-throughput screening (HTS) assay, which
were simulated by perturbing associated model parameters accordingly. Snapshots of the
model treated with varying levels of 5HPP-33 were compared against experimental
images of human umbilical vein endothelial cells (HUVECs) stimulated to undergo
vasculogenesis and subsequently exposed to different concentrations of 5HPP-33. These
comparisons were made both qualitatively and quantitatively, as shown in Figure 17,
through image analysis software known as Angiotool. These indicate similar features in
the resulting computational and experimental networks, such as increased vessel plexus
disruption and cellular clustering as the concentrations of 5HPP-33 are increased. While

Figure 17: Top row shows snapshots of the vasculogenesis ABM in response to 0 µM (control), 4.44
µM (low) and 40 µM (high) concentrations of 5HPP-33 from left to right, respectively. Bottom row
shows images of experimental images of human umbilical vein endothelial cells stimulated to undergo
angiogenesis in the presence of 0, 4.44 and 40 µM of 5HPP-33. Both rows were analyzed using
AngioTool software to show staining and segmenting of endothelial cells (ECs), with non-ECs set to
black. Modified from [258]
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this experiment thus serves as a proof-of-concept of the ABM, it nevertheless indicates
how other molecules could be rapidly studied using the ABM following calibration with
HTS results in order to generate hypotheses regarding their effects on vasculogenesis.
2.4.6. Muscle Atrophy
The next ABM investigated changes in muscle behavior in response to atrophy
[261]. Muscle atrophy causes 1.5% ($18.5 billion) of healthcare costs for elderly in the
United States, and is an important factor in medically-related bed rest or immobilization.
The researchers note that muscle response is well-characterized in terms of the many
cellular and molecular consequences resulting from cellular interactions within the
responding muscle. The difficulty lies in integrating this knowledge to predict how any
individual muscle responds to disuse, which prompted the adoption of an agent-based
computational model.
We show an image of the model in Figure 18, along with the different agents and
their respective rules in Figures 19 and 20, respectively. Briefly, the model is of a 3 µmthick cross-section of muscle, made of a single muscle fascicle composed of 14 muscle

Figure 18: Representative images of muscle atrophy ABM at 0, 7, 14 and 28 computational days.
Modified from [259]
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Figure 19: List of cellular behaviors in response to chemical signals in the muscle atrophy ABM.
Modified from [259]

Figure 20: Equations for the behavioral rules used by the cells in the muscle atrophy ABM. Modified
from [259]
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fibers. Fibers are agents that can exist as one of four types (I, IIA, IIB or IID) with a
defined cross-sectional area, and that can secrete IGF or undergo protein synthesis or
degradation. The muscle exists in a cube environment with fibroblast agents. Each
fibroblast can be thought of as existing in the center patch of a 3x3 patch grid, meaning
the eight surrounding patches serve as the agent’s local neighborhood. Fibroblasts can
undergo proliferation or apoptosis, migrate across the muscle and/or produce chemical
signals such as IGF, TGF, PDGF and TNF. The effects of these signals on the muscle
behavior are specified through a set of equation rules, which can affect cell migration,
cellular proliferation, cellular apoptosis, protein synthesis and protein degradation.
Utilizing previously published experimental data regarding muscle fiber composition and
geometry, the researchers tailored the muscle fiber to represent a variety of muscles
across the body, and then simulated their atrophy over time. Each model time step
corresponds to 1 hour, with simulations running for 28 days of model time. All results
were the average of 10 simulations, which allows for a total of 140 fibers in order for the
fiber number to fall within the range of published experimental studies.
Many of their model findings addressed current questions governing muscle
behavior. For instance, while muscles from the same region experienced a similar degree
of atrophy, none of their individual muscle architecture parameters could predict the
degree of atrophy for an individual muscle. These parameters include the percent
composition of each fiber type and the initial average cross-sectional area for each fiber
type. This suggests that the extent of atrophy is an emergent feature resulting from the
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combination of muscle architecture parameters, and that the underlying rules governing
an individual’s muscle behavior are the same, regardless of its location.
The researchers also used the model to construct theoretical muscles composed
purely of individual fiber types to better understand the behavior of the fibers. For
instance, they determined that muscles composed purely of IIB fibers underwent less
atrophy than those composed entirely of type I. The researchers also used their model to
address muscle behavior at the cellular level. As shown in Figure 21, increasing the initial

Figure 21: Percent of muscle atrophy in response to differing fibroblast to fiber ratios (A, D), TNF
production (B, E) and IGF-1 production (C, F) in different fiber types (A-C) and different muscles
(D-F) in the muscle atrophy ABM. All measurements are averages of 10 simulations. # indicates a
statistically significant difference relative to the baseline value at x=0, as determined by a 1-way
ANOVA, p < 0.01. Modified from [259]
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number of fibroblasts increased the degree of atrophy for all fiber types within the model,
while decreasing this number resulted in less atrophy in only two of the fiber types.
Interestingly, increasing or decreasing IGF-1 production by muscle fibers and fibroblasts
had no significant effect on atrophy, while increasing the amount of TNF released by
fibroblasts resulted in increased atrophy. The researchers emphasized that this notion of
fibroblasts and their secreted factors having critical effects on muscle atrophy is one that
could now be further explored.
2.4.7. Lung Inflammation And Fibrosis
The final model we examine is a 2011 model of inflammation and fibrosis in the
lung [262], aimed at determining how inhalation of particulate matter leads to different
inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD).
Though chronic airway disease is often linked to repeated inhalation of particulate matter
such as cigarette smoke or pollutants, this is not always the case, underscoring the need to
better understand the inflammatory response in the lung to determine the factors that lead
to disease states.
The researchers note that while there have been many in vitro, in vivo and ex vivo models
of chronic airway disease, none of them seem to have the potential to fully recapitulate
the development of COPD in humans. While in vivo and ex vivo models can answer
focused questions about the details of cellular behaviors, they do not contain the complete
set of cells activated in COPD. In vivo animal models are closer to the human model, but
still differ in multiple respects such as anatomy, genetics, and the details of the immune
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system. An in silico approach would thus enable them to more fully incorporate all the
components of the inflammatory response in the lung. Agent-based modeling was
proposed because it could enable them to rapidly modulate multiple variables and
observe the effects on the lung.
As a first step in creating a rigorous model of the response, the researchers created
a relatively simple “lumped parameter” ABM that simplifies the geometry of the lung
and collapses multiple cells and parameters into single types. The environment is a 50 x
50 patch grid upon which cells can migrate. Key chemical signals released into this
environment include TNF (a lumped version of all pro-inflammatory cytokines and a
surrogate for proteases and reactive oxygen species that damage lung tissue) and TGF-β

Figure 22: Schematic showing the interactions in the lung inflammation ABM. Macrophages and
fibroblasts are model agents. TNF and TGF-β1 are released by macrophages, while collagen is
released by fibroblasts. Modified from [260]
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(a lumped version of anti-inflammatory cytokines, pro-fibrotic cytokines and growth
factors). The cellular agents include macrophages (a lumped version of macrophages,
neutrophils, lymphocytes and other inflammatory cells), fibroblasts, and particulate
matter. A schematic of the key interactions is shown in Figure 22. Briefly, encounter with
particulate matter makes macrophages enter an activated state in which they release TNF,
which draws in additional macrophages and deals direct damage to the tissue patch on
which it is released. Once the particulate matter is cleared, the macrophages release TGFβ, which antagonizes TNF production and serves as a chemoattractant for fibroblasts,
which repair patches with tissue damage and deposit collagen onto the patches. Both
macrophages and fibroblasts consider three patches at each timepoint: the

Figure 23: A, B, and C show the lung inflammation ABM during the self-resolving state, localized
damage and fibrosis state and widespread damage and fibrosis state, respectively. D-F show lung
slices gathered from mice exposed to cigarette smoke for 5 weeks. Arrows in E and F show
inflammatory aggregates within the slice. Modified from [260]
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Figure 24: Mean ± standard deviations for (A) tissue life (a marker of inflammation measured by
averaging the health of each environment patch, where 100 indicates complete health and 0 indicates
complete damage), and total number of (B) macrophages, (C) fibroblasts and (D) collagen in the
model for each of the three model states throughout the timecourse of the simulation in the lung
inflammation ABM. Each result is an average of 10 representative simulations for each state. All
numbers are in arbitrary units. Modified from [260]

Figure 25: Mean ± standard deviations for total number of (A) pro-inflammatory cytokines, (B) antiinflammatory cytokines, (C) pro-inflammatory cytokines per macrophage and (D) anti-inflammatory
cytokines per macrophage for each of the three model states throughout the timecourse of the
simulation in the lung inflammation ABM. Each result is an average of 10 representative simulations
for each state. All numbers are in arbitrary units. Modified from [260]
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patch directly ahead of their current direction, as well as the patches left and right of that
patch. The rules governing the behaviors are based on known biological behavior in
chronic airway diseases as well as insights from previous models of inflammation and
wound healing. Five, 10, 15 or 20 particles were randomly distributed throughout the
airway every 50, 100 or 200 time steps, with a maximum particulate exposure of 50, 100
or 200 times. Each of these potential combinations was run for 40 times, each for 10,000
time steps to determine if any result in a disease state.
Interestingly, these experimental results indicated three distinct model states, as
shown qualitatively in Figures 23 and quantitatively in Figures 24 and 25. In the first,
described as self-resolving, by the end of the simulation the model had cleared the
particles without sustained tissue damage over time. In the second state, described as
localized damage and fibrosis, regions of tissue damage slowly emerged throughout the
model environment, with a gradual increase in inflammation and local damage that
continued even after exposure had ceased. Macrophages and fibroblasts remained
localized to the periphery of the sites of damage, along with the majority of collagen
deposition. Interestingly, only pro-inflammatory cytokines remained elevated at the end
of the simulation while anti-inflammatory cytokines were absent. The third state was
described as systemic damage and fibrosis, with rampant tissue damage and a random
distribution of collagen deposition throughout the environment. This state is marked by
an early period of gradual tissue damage, followed by a rapid period of significant
damage that results in complete destruction of the tissue region. Furthermore, both proinflammatory and anti-inflammatory cytokines remained elevated at the end of the
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simulation, and there was a significantly elevated number of macrophages and
fibroblasts.
Thus even with this very simplified model, the researchers produced three distinct
states of the lung in response to chronic particulate exposure. Interestingly, the
researchers had not anticipated the localized damage state arising from the interactions in
their model, further indicating the ABM’s ability to give rise to emergent phenomena.
The researchers also noted that increased particulate exposure at higher frequencies and
shorter intervals increases the likelihood of the lung falling into a localized or systemic
damage state. They speculated that the second and third states correspond most closely to
granulomas and COPD, respectively. In order to increase the model’s utility, they
proposed expanding the range of cells included in the model (including breaking the
lumped cell types into their constitutive components), and updating the environment to
more closely mimic specific lung tissue structures of interest. Nevertheless, this was an
important first step in demonstrating that ABM’s can lead to multiple, emergent disease
states within the lung.

2.5. Conclusions
We have highlighted seven different ABMs of biological systems that explore the
underlying spatiotemporal dynamics of a variety of biomedical systems. Some of these
models test notions about the behavior of the system that were previously tested
experimentally, generating results consistent with what had been observed. This indicates
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the power of this form of modeling to rapidly test hypotheses and generate results that are
consistent with in vivo experiments. Other models presented here critically test the
systems in ways that would be difficult (if not impossible) to determine experimentally,
leading to proposed insights about the underlying biological behavior. These models also
reveal important emergent phenomena, in some cases indicating behavior that is
governed by the unique combination of multiple parameters. This highlights the need to
account for all of these interactions in hypothesis testing—as this form of modeling
allows—in order to generate experimentally useful results. The ability of agent-based
modeling to have emergent behavior arise naturally from simple rules without prior
knowledge that this will happen is a key advantage of this form of modeling, illustrating
the utility of ABM’s at the initial stages of biomedical investigation.
While the field of medically oriented ABMs yields great promise, in many
instances we are still in the early stages of using them to advance clinical knowledge.
Many of the published studies shown here serve as a proof of concept by recapitulating
known experimental findings, or are exploratory into the nature of the biological behavior
and require further development and testing to yield clinically useful insights. The breast
cancer and melanoma ABMs stand in contrast, perhaps due to the relatively more
widespread use of ABMs in the study of cancer. The breast cancer findings led to the
identification of a gene not previously considered as a critical player in determining the
type of breast tumors that arise in an individual, while the melanoma ABM led to
identification of a potential treatment and its effects on the tumor. This comes closest to
indicating the true power of agent-based modeling: to test concrete, novel predictions
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regarding the nature and treatment of clinical diseases using insights derived from
previous literature.
In conclusion, we have shown that agent-based modeling is a powerful form of
virtual experimentation that enables us to model a wide range of biological systems. It is
our hope that more biological researchers will consider ABM’s as a first step in critically
vetting hypotheses about the system behavior prior to experimental work in the lab, in
order to accelerate the advancement of novel, useful insights into biomedical systems.
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CHAPTER 3: THE INFLAMMATORY TWITCH
3.1. Introduction
The inflammatory response is a general biological defense mechanism for battling
invading microbes or attending to injury. The symptomatic manifestations of
inflammation, namely tumor, rugor, calor and dolor, reflect myriad molecular events that
orchestrate a variety of resident and recruited cell types to operate in a specific manner
within the affected tissue [1]. Clearly, turning on an appropriate inflammatory response in
time of need is critical to an organism’s survival. However, turning the response off again
when it is no longer needed is equally important. Indeed, failure to resolve the
inflammatory response is presumably behind the chronic inflammatory conditions that
characterize many common diseases. This raises the general question as to what strategy
the body uses to control both the up regulation and the down regulation of inflammation.
Negative feedback has been proposed as a means for controlling the extent of allergic
inflammation [2]. However, recent work suggests this does not adequately explain the
relationship between the stimulus and the allergic response [3]. Another possibility is that
these two events are subject to independent decision criteria; up regulation of
inflammation is directed by a control mechanism that reacts to the appearance of a threat,
while down regulation is controlled by a separate mechanism that detects the threat’s
disappearance. This scenario is compelling because of its ready analogy to the fighting of
military battles. However, it is not the only possibility.
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An alternative control strategy for the inflammatory response is suggested by the
formal similarity of its task structure to that of skeletal muscle. The inflammatory
response is something that an organism must be ready to invoke, without warning, any
time a threat arises, and yet it must dissipate when no longer needed. The same applies to
muscle activation; muscles must be ready to generate force whenever the brain decides to
undertake some task, but must cease to do so as soon as the task is completed. However,
force generation and cessation in muscle are not subject to separate decision processes,
but rather are controlled jointly via frequency modulation. Specifically, a muscle
continues to do the job asked of it so long as it receives a steady stream of periodic
electrical impulses, the frequency of the impulses dictating the level of force. Once the
need for the task has passed, however, the impulses stop and the muscle returns to
quiescence. The functional unit of this control strategy is the muscle twitch, a transient
manifestation of force driven by a sequence of events that includes not only those that
cause force to escalate, but also those that bring about its subsequent resolution. In other
words, the termination of a muscle twitch is an inevitable consequence of its initiation, so
continuation and/or escalation of force is simply a consequence of how individual
twitches summate when invoked in rapid succession. The singular advantage of this type
of control strategy is that it obviates the need for additional decision resources beyond
those involved in activation.
The above reasoning leads us to contemplate the possibility that inflammation
might be controlled in a similar manner to skeletal muscle, that is, via the repetitive
generation of self-limited transient unitary responses. This analogy implies the existence
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of an “inflammatory twitch”, an inevitably resolving sequence of cellular events having
formal similarity to a muscle twitch, albeit it over a greatly extended time scale. Further
questions then arise as to the extent of this analogy. What is the duration of an
inflammatory twitch? Can multiple inflammatory twitches summate in the same manner
as muscle twitches? Do inflammatory twitches give rise to a post-initiation refractory
period? Answering these questions might elucidate important aspects of how the general
host inflammatory response is controlled, and possibly even how its control might fail in
disease.
Accordingly, the goal of the present study was to investigate the plausibility of the
inflammatory twitch hypothesis. We focused in particular on allergic inflammation in the
lung because this condition has been well characterized in terms of the cell types
involved [1]. Also, we have previously observed that when allergically sensitized mice
are continuously challenged with antigen over a period of weeks, their inflammatory
response does not continue indefinitely but instead eventually resolves toward baseline
[4]. Furthermore, if antigen challenge is interrupted for several weeks and then
reinitiated, the animals again mount a vigorous inflammatory response [5]. These
observations appear to be consistent with our notion of the inflammatory twitch, but they
do not demonstrate that it is feasible relative to the interactions of all the cells involved.
Allergic inflammation in the lung is a complex event, localized around the lung and its
associated mediastinal lymph nodes, yet involving a variety of cells recruited at different
times from outside the organ [6-7]. It is not immediately obvious that a twitch-like self-
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limited response to the appearance of an antigen in the lung could actually manifest from
a system with these features.
Testing the plausibility of the inflammatory twitch hypothesis thus requires that
the spatiotemporal dynamics of the various cellular players and chemical signals involved
be taken into account. In the present study we undertook this task computationally,
employing a modeling technique that appears ideally suited to this purpose. This
technique, known as agent-based modeling, allowed us to simulate the dynamic
environment comprising the pulmonary capillary and its associated alveolar
compartment, and to determine if something akin to an inflammatory twitch is indeed
possible, and what its temporal and spatial morphology might look like.

3.2. Computational Methods
3.2.1. Model Structure
We used NetLogo 4.1.3 freeware [8] to design an agent-based model that
simulates allergic inflammation in an alveolus of the lung in response to antigen
stimulation. The model uses two types of variables known respectively as patches and
agents. Patches represent fixed pieces of the local environment, and thus contain local
variables representing information about that area. In our model of the allergic
inflammatory response, the patches represent the capillary and alveolus as well as the
endothelial barrier between them. (The sizes of the capillary and alveolar spaces are
arbitrary.) Each alveolar patch has a local parameter known as “tissue-life”, which
indicates the amount of tissue damage that has occurred on that patch. It is set between 0
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and 100, where 100 corresponds to full health and 0 indicates a fully destroyed patch.
Thus the average health of all alveolar patches represents the average health of the
alveolus.
In contrast to patches, which represent the environment, agents represent
individual entities capable of moving across patches and interacting with surrounding
patches and with other agents. The agents in our model are the multiple cell types
involved in the allergic inflammatory response in the lung. The behavior of the model is
thus determined by the collection of rules that each agent obeys.

Figure 26: Schema for allergic inflammation in the lung. Mast cells and APCs are activated upon
encountering Particles (i.e. antigen), which then leads to the indicated cascades
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Our overall schema for the allergic response is shown in Figure 26, and includes
what we believe to be the key mechanisms and cell types that are involved. To increase
the manageability of the model we have not included all known details of allergic
inflammation in this schema. For example, following the approach of Brown et al. [8], we
lumped dendritic cells, B cells and macrophages together into a single Antigen Presenting
Cell (APC) type. Similarly, neutrophils, eosinophils and other cell types that cause local
tissue damage are merged into a single Pro-Inflammatory Cell (PIC) type, while
fibroblasts and other cells that are involved in tissue repair are combined into a single
Anti-Inflammatory Cell (AIC) type. This grouping of cell types is, of course, a gross over
simplification of reality, but we believe it represents the greatest degree of coarsegraining that could reasonably be applied to the cellular community so that it still retains
the ability to exhibit competition between inflammatory and reparative processes.
The inflammatory response is initiated by the sudden presence of Particles at
random locations in the alveolar space. Both Mast Cells and APCs are involved in this
initiation. We focus on these two cell types because in vivo, mast cells release both
preformed and synthesized chemical mediators such as prostaglandins, leukotrienes and
vasoactive amines upon cross-linking of their receptors by bound antigen [1]. This leads
to many of the symptoms that are observed in the allergic inflammatory response, such as
vasodilation and bronchoconstriction [1]. In addition, APCs process antigen particles via
pattern-recognition receptors, such as Toll-like receptors, and subsequently become
activated. This affects cytokine production in such a way as to ultimately affect the T-cell
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population, leading to amplification and perpetuation of the inflammatory phase of the
allergic response [9].
The model was initialized with 5 Mast Cells, 10 APCs and 10 PICs in the
alveolus, and the same numbers in the capillary. The alveolus was also initialized with 20
AICs, 10 helper T-cells and 10 regulatory T-cells, while the capillary contained 5 helperT and regulatory T-Cells. The capillary acts as a reservoir of cells, so if any of these cells
dropped below these baseline values in the capillary, the appropriate number of
additional cells was randomly added to the capillary space. The capillary effectively acts
as a source and sink for cells in the alveolus. Thus while the size of these spaces are
arbitrary, changing the size of the capillary would not have a significant effect on the
model.
The model includes an endothelial barrier between the capillary and the alveolus.
Pores in the barrier allow restricted cell movement between the two spaces. If the sum of
various pro-inflammatory chemical signals, namely Granules and Pro-Inflammatory
Cytokines (PI Cytokines) in the lung space is greater than a critical value (arbitrarily
chosen as 200 for this model), the barrier is removed. This simulates the effects of
vasodilation and endothelial leak by allowing uninhibited cell movement between the
capillary and alveolar spaces.
3.2.2. Model Dynamics
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Inflammation in the model is initiated by random placement of a certain number
of Particles throughout the alveolus [8]. Additional Particles may be placed at any later
time point in order to simulate continual stimulation of the inflammatory response.
All cell movement in the model is probabilistic. If there is no reason for a cell to
move in any particular direction, the cell moves a distance of one patch either forward,
back, right or left with equal probability at each time step. However, if a patch contains a
signal to which the cell is responsive, the probability of movement to that patch will be
increased proportional to the strength of the signal. Thus, while on average a cell will
move in the direction of the strongest signal, the movement at any particular time step
may not be in this direction.
Diffusion of chemical signals (i.e. Granules, PI Cytokines and AI Cytokines) is
simulated by randomly distributing a specified fraction of each signal on a patch to its
adjacent patches at each time step. Removal of these substances by enzymes, blood flow,
etc. is simulated by having their strengths decrease by set proportions (specific for each
substance) at each time step [8].
The lifespan of each cell type in the model follows an exponential distribution
that is implemented as follows. At each time step, and for each cell in the model, we
generate a random number on the uniform distribution between 0 and 1. If this number is
greater than a critical value specific for the cell type in question then the cell is
eliminated. Mast Cells and APCs are relatively long-lived compared to most of the other
cell types [6, 10]. (While the most abundant CD4 T-cell type, memory T cells, are also
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long-lived, we do not consider them long-lived in our model because they may only be
active for a shorter period of time following antigen exposure.) We thus chose the critical
value for Mast Cells and APCs to be 0.9997 giving them an estimated mean life span of
2500 time steps, while the critical value for all the other cell types except the AICs was
0.9978 giving them an estimated mean lifespan of 200 time steps. The AICs were
allowed to live indefinitely since fibroblasts are known to be very long-lived relative to
the other cell types [11-12].
3.2.3. Agent Rules
The overall behavior of the model is a consequence of the way in which its agents (the
cell types described above) behave. The behavior of each agent is governed by a set of
rules designed to capture the essential elements of actual biological behavior. The various
agents in our model are listed in Table 1 together with the signals to which they respond
and the rules that govern their behavior. The rule sets for each cell type are generally
similar in that they cause the cells to move towards and become activated by certain
chemical signals, and then release chemical signals of their own into the surrounding
patches.
The initial cell types involved in the allergic response are Mast Cells and APCs,
which both respond to Particles and release chemical signals that initiate the subsequent
events of the allergic response. Mast Cells accomplish this task by binding Particles on
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Table 1: Summary of all agents and their respective rules included in the model

Cell Type
Mast Cell
(immature)
Mast Cell
(mature)

Moves Towards
Attractants

APC

Particles

Helper T Cell

Granules,
APCSignals

Pro-Inflammatory
Cell

Pro-Inflammatory
Cytokines,
Granules

T-Regulatory Cell

Pro-Inflammatory
Cytokines

AntiInflammatory Cell

Patches with
Health < 100

Particles,
Attractants

Rule
Moves preferentially to attractants, or
randomly if there are no attractants
Upon binding Particle, releases Granules for
10 time steps. Becomes inactive for user-set
time if encounters user-set number of Particles
While digesting Particle, releases APC
Signals. Becomes inactive for user-set time if
encounters user-set number of Particles
If moving towards Granules and/or APCs,
releases Pro-Inflammatory Cytokines for 10
time steps. Afterwards, if there is a strong
chemical signal on the current patch, converts
into a Pro-Inflammatory Cell
If moving towards Pro-Inflammatory
Cytokines and/or Granules, become activated
for 10 time steps. While activated, release ProInflammatory Cytokines and Attractants.
Also, subtract 5 from the health of the patch
currently on if cell has moved towards a
chemical signal, or 2 if not. At the end of
activation, the cell dies if there is a chemical
signal on the current patch
If moving towards Pro-Inflammatory
Cytokines, release Anti-Inflammatory
Cytokines
If on a patch with health < 100, add 1 to that
patch’s health parameter at each time step

the patch they are currently on and then releasing a user-specified number of Granules
into the surrounding patches for 10 time steps [1]. Mast Cells initially exist in an
immature state until a user-specified amount of time has passed, at which point they
become mature and functional. Mature Mast Cells move towards Particles on adjacent
patches, while immature Mast Cells move towards released Attractants or else they move
randomly [13-14]. In contrast, APCs eliminate Particles on the patch they are currently
97

on, releasing APC Signals into the surrounding patches in the process [15]. When either a
PIC or a Mast Cell encounters a particle, it becomes sensitized. However, previous
studies have shown that Mast Cells and APCs become desensitized after a period of
continual stimulation (13). Accordingly, we allow Mast Cells and APCs in the model to
be sensitized so long as they have encountered fewer than 5 particles, but they revert to a
quiescent state otherwise.
Granules and APCSignals serve as chemical signals for helper T-cells, i.e. these
cells preferentially move towards patches with high concentrations of these chemicals.
Upon landing on these patches, helper T-cells are activated for 10 time steps during
which they release PI Cytokines [1]. Afterwards they convert to PICs if they are still on
patches with high PI Cytokine levels.
PICs are signaled by both Granules and PI Cytokines, and become activated upon
landing on a patch with high concentrations of these signals. They release PI Cytokines
and Attractants for 10 activation steps and then die afterwards. If activated PICs sense a
strong signal on at least one of the nearby patches, they subtract 5 from the tissue-life
parameter of the patch they are currently on. Otherwise, they subtract 2.
The combination of both helper-T cell and PIC actions creates a positive feedback
loop of PIC recruitment and PI Cytokine release. This loop is ultimately hindered by TRegulatory cells that respond to the PI Cytokine chemical signal. Unlike PICs or helper
T-cells, however, T-Regulatory cells remained permanently activated. Whenever they
move towards PI Cytokines, T-Regulatory cells release AI Cytokines that subtract from
98

the amount of PI Cytokines on a patch and thus dampen the pro-inflammatory signal and
its effect [1].
In contrast to the other cell types, AICs move preferentially towards damaged
tissue, i.e. any patch with a tissue-life parameter less than 100. Upon reaching a damaged
tissue patch, an AIC will remain there and with each time step will add 1 to the TissueLife parameter of the patch until it reaches 100. At that point, the cells will either move
towards another patch with a tissue-life parameter less than 100 or else it will move
randomly. This behavior comes directly from the agent-based model developed by Brown
et al. [8].
Figure 27 shows an example output of the model. The baseline state of the model
prior to application of any Particles is shown in Panel 1, where the light gray color

Figure 27: Three snapshots of the model at rest, with increasing levels of lung damage from left to
right. The red area is the blood, the gray area represents the alveolus, the white area represents air,
and the blue outlines are barriers between these respective spaces. The leaky barrier between the
blood and alveolus can disappear during an allergic reaction (as seen in the middle figure),
representing vasodilation. Darker gray areas indicate damaged lung tissue. The other shapes
dispersed throughout the blood and alveolus spaces represent different cell types included in the
model
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corresponds to full tissue health. Panels 2 and 3 show increasing levels of lung damage
indicated by the progressively darkening alveolar patches.

3.3. Results
All model simulations began with a run-in period of 250 time steps with no
stimulation, which was found was sufficient to have the model achieve steady state.
Figure 28 shows the time course of Tissue Health over 15,000 times steps after the run-in
period (average of 10 independent simulations) resulting from stimulating the model with
85 Particles placed randomly within the Alveolar Space every 20 times steps. This caused
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Figure 28: Average of 10 simulations of Tissue Health (defined as 0 for totally damaged and 100 for
completely healthy) for the Alveolar Space of the model a function of the number of time steps when
85 Particles are placed randomly within the Alveolar Space every 20 time steps

100

oscillations in Tissue Health of progressively decreasing amplitude. Figure 29 shows an
expanded view of the initial portion of the simulation upon which we have superimposed
data taken from a study by Tanaka et al. [3] who subjected ovalbumin-sensitized mice to
3 weeks of daily stimulation with ovalbumin aerosol. The inflammatory status of the
mice, including a variety of cell types in bronchoalveolar lavage fluid, were measured at
4 time points during this period to provide a time-course for the inflammatory response.
The data shown consist of the counts of pro-inflammatory cell types in Fig. 29A
(leukocytes plus lymphocytes), and macrophages (taken to represent anti-inflammatory
cells) in Fig. 29B. The two cell type counts from Tanaka et al. [3] shown in Fig. 29 have
been scaled to be comparable to the simulated cell counts for ease of comparison of the
shapes of these relationships with time. In addition, the time scales of the simulations
have been adjusted so that 100 time steps equals 1 week of real time, which leads to a
good match between the simulated and experimental cell count profiles.
Figure 30 shows the model behavior when it was subjected to the same
stimulation regimen as used by Riesenfeld et al. [5], namely 3 consecutive daily
exposures to antigen followed by a single exposure one month later. The dip in Tissue
Health seen with the 3 early Particle administrations is recapitulated, albeit it to a
somewhat reduced degree, when Particles are administered again after the break. This
shows that, given sufficient time, the model will recover sufficiently towards it naïve
state that it can mount a second response when re-stimulated.
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Figure 29: Pro- (top) and anti- (bottom) inflammatory cell types from the early portion of
the simulation shown in Fig. 3, together with counts of pro-inflammatory cells (leukocytes and
lymphocytes) and a nominal anti-inflammatory cell type (macrophages) from bronchalveolar lavage
fluid determined experimentally by Tanaka et al. (3) in sensitized mice exposed to ovalbumin daily
for 3 weeks. The experimental counts have been scaled vertically for ease of comparison of their
temporal relationships to the simulated data. The simulated time base (i.e. number of time steps)
have been divided by 100 to convert to real time in weeks
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Figure 30: Average of ten simulations in which 3 Particle challenges were placed in the Alveolar
Space at roughly once per day followed by a 4th challenge one month later (the vertical arrows
indicate the times of challenge)

Finally, Figure 31 shows what happens to Tissue Health when the interval
between application of Particles is varied. Stimulation periods of 0.5, 1 and 2 weeks yield
rather similar results, characterized by an initial pronounced dip in Tissue Health
followed by decreasing dips and more chaotic behavior as time progresses. By contrast,
an application interval of 10 weeks produces regular marked oscillations in Tissue Health
that continue unabated.
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Figure 31: Tissue Health versus number of time steps when Particles were placed in the Alveolar
Space every A) 0.5, B) 1, C) 2 and D) 10 weeks. All plots are an average of ten simulations
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3.4. Discussion
From the perspective of survival, turning off the body’s defense mechanisms
when they are no longer needed is just as important as turning them on in response to a
threat. Indeed, many chronic and debilitating diseases appear to be manifestations of a
host response that fails to resolve when it should. Elucidating the pathophysiology of
these diseases amounts in large part to finding out why control of the host response fails,
and this begins with consideration of how it is controlled normally. Our thinking on this
subject tends to be influenced by the common view of the host response as the waging of
a military battle in which an army of defenders attempts to vanquish an invading foe. The
danger with this analogy, however, is that it leads to the supposition of top-down
command, yet there is no obvious analog in living organisms of the General who surveys
a battle scene and gives orders based on what is perceived to be happening.
Even more problematic, the military analogy suggests separate command and
control systems for turning on the host response when it is needed, and then turning it off
again when its job is done. Turning the response on presents no particular conceptual
difficulty because it merely requires detection of a threat, and the various specialized
cells of the immune system do just that. Turning the response off again via a separate
controller is a problem, however, because this would require detection of the absence of a
threat, something that can only be done either by an intelligent entity capable of
remembering all possible threats or by an innate sentinel poised to recognize molecular
patterns indicative of “health” or threat absence, neither of which seems very likely.
These considerations led us to postulate that the host response, and the allergic
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inflammatory response in particular, is controlled in a manner similar to that employed by
the nervous system to control the force exerted by skeletal muscles. This control is
achieved by the repetitive invocation of a unitary event of short duration whose
resolution is built into its initiation, namely the muscle twitch. Force persists so long as
twitches keep being initiated by neuronal action potentials, which themselves are
instigated by the brain’s desire to move some part of the body. Control of muscle force
thus requires only detection of the presence of something, but not detection of the
absence of something.
This line of reasoning leads immediately to the notion of the inflammatory twitch
as the unit of response of the immune system to an invader, but it brings with it some
ancillary analogs. Most obvious is refractoriness, a period following twitch initiation
during which a second twitch cannot be instigated. Refractoriness is a necessary
requirement for twitch morphology because it ensures that the events involved in
generating the twitch are properly turned off before they can be reinitiated. In the case of
muscle force, the timing of refractoriness may allow for stacking (summation) of the
forces from multiple twitches as occurs in skeletal muscle, or it may prevent stacking as
is the case for cardiac muscle. It is not obvious a priori which strategy the immune
system would choose, but we have previously obtained evidence from sensitized mice
treated with sequential daily exposures to a foreign protein (ovalbumin) that the latter
situation may pertain to allergic inflammation of the lung. Inflammation peaks after about
3 days of exposure, and then gradually abates as exposures are continued over days to
weeks [4-5]. This is referred to as tolerization [16], and is thought to involve T-regulatory
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cells. Resting the animals for several weeks, however, allows them to once again respond
vigorously to a subsequent ovalbumin challenge [5], suggesting that the inflammatory
twitch in these animals lasts on the order of weeks and has a refractory character that
prevents them from stacking.
These findings are recapitulated by the agent-based model we developed in the
present study, which exhibits clear oscillatory behavior following continual stimulation
with Particles (the analog of antigen exposure in mice). Of particular note is the fact that,
for most stimulation regimens, the largest and most well defined oscillations are observed
early on, and these are followed by behavior that becomes progressively more chaotic
with less well defined peaks (Figs. 28 and 31). On the other hand, if the period between
successive stimulations is long enough to allow resolution of the response to each
challenge, the oscillations remain sharply defined with time (Fig. 30d), resembling a
series of well separated twitches that are unable to summate. The twitch hypothesis is
further supported in the model by our finding that allowing the model to rest for a period
of time results in a reiteration of the initial peaked response upon re-stimulation (Fig. 30),
similar to our previous observations in mice [5].
Inferences drawn from the behavior of our agent-based model must be viewed in
light of its numerous simplifying assumptions, which were made in the interests of
conceptual and computational tractability. Many of these assumptions relate to the way in
which individual biological entities behave. For example, we assume that cells have
infinite stores of the chemical signals they release, and that the epithelium plays a purely
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passive role as a physical barrier to cell movement, which from our own work [17] and
that of others [18] is clearly an oversimplification. Furthermore, the alveolar airspace in
the model is inaccessible to any cell type, whereas in reality cells do cross the epithelial
barrier and some are cleared via the airways, which creates an additional sink for cells
from the alveolar compartment. This might affect the magnitude and/or dynamics of
predicted inflammatory oscillations, but would likely not affect their actual existence.
Similar remarks can be made with respect to our model assumption that cells do not
divide. Fibroblasts, for example, actively divide during the repair phase of the allergic
response [19], which might not significantly affect the prediction of the early
inflammatory oscillations but could result in greater suppression of the subsequent
inflammatory activity (such as beyond 5000 time steps in Fig. 28).
The most important assumptions in the model, however, relate to the way in
which we coarse-grain the myriad details of reality into a much smaller number of
independent components. Coarse graining is a hierarchical process, the success of which
depends on appropriate binning of the underlying biological details into their various
model groups. In our model, for example, we coarse-grain the dynamics of cell
movement by lumping all the different movement velocities into a single average rate of
random movement from location to location, regardless of whether or not the cells are
activated. This presupposes that cell movement per se is the most important feature of the
ability of cells to travel between different locations, and that different cells moving at
different velocities is of secondary importance, following the approach taken by Brown et
al. [8]. In reality, for example, fibroblasts tend to remain localized to fixed locations
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within the lung, which could mean that nearby regions could be maintained on average in
a more healthy state compared to regions far from a fibroblast, which could increase the
topographical heterogeneity of predicted tissue damage in the model. We also coarsegrain cell size by assuming it is the same for all cell types.
Similarly, by lumping multiple cell types into only two functional groups, the
PIC’s and AIC’s, we assume that it is simply the existence of competing cell types that is
paramount, while the existence of different phenotypes within each cell group is of
secondary importance. For example, we ignore differences in lifespan and behavior
between cells neutrophils and eosinophils, both of which are lumped together into the
PIC category. The question thus remains as to whether such a crude level of coarsegraining causes us to miss some crucial detail of overall system behavior that would have
become apparent had we divided the PIC and AIC groups into sub-groups with different
properties. There are many known details of cell behavior that could be investigated in
this regard. For example, the alveolar macrophage has a lifespan between that of other
PICs and AICs, and can initially behave as a PIC but then switch to an AIC depending on
environmental stimuli [20], and indeed we invoked the macrophage data from Tanaka et
al. [3] as representative anti-inflammatory cell types in Fig. 4. Mast cells and APCs can
signal to cells such as monocytes and macrophages, causing them to turn into PICs [2122]. Some pro-inflammatory cytokines, such as TNF-alpha, inhibit their own synthesis
which self-limits their production [23]. Thus, the number of ways in which we might
delve into a finer level of model coarse-graining is enormous. For the time being,
however, we will let ourselves be guided by the notion that it is the competition between
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temporally offset pro- and anti-inflammatory processes that gives rise to the
inflammatory oscillations predicted by our model, and which support the inflammatory
twitch hypothesis. Accordingly, we take the position that the details alluded to above,
while clearly important for refining the details of the model predictions, are not crucial to
the prediction of their actual existence.
The behavior of our model can thus not be taken to constitute proof or otherwise
of a biological theory. However, it does provide a test of plausibility to an extent that is
impossible to achieve through any other approach. The allergic inflammatory response
involves a large number of mutually interacting cell types, each playing different roles.
Determining the details of the ensemble behavior of such a complex system defies human
intuition. Agent-based computational modeling, on the other hand, allows one to estimate
how the system might possibly behave within its spatiotemporal constraints. This
approach has been exploited convincingly by Vodovotz and colleagues in the exploration
of a number of aspects of the inflammatory response [8]. In the case of the present model,
we have demonstrated that the major cell types involved in the allergic inflammatory
response could indeed conspire to produce collective behavior in the lung that is formally
similar in many important respects to the muscle twitch.
An important feature of the muscle twitch is the fact that it manifests in cycles
where stimulation is continual. Support for the inflammatory twitch hypothesis in this
regard comes from the experimental work by Tanaka et al. [24] showing that mice
undergoing chronic antigen challenge have cytokine levels that peak 1 week after
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initiation of the antigen challenge and then decrease for up to 3 weeks afterward. These
cyclic biomarkers are consistent with the waxing and waning of the hyperresponsive
phenotype that occurs in allergic mice [5]. Such observations are consistent with the
duration of this inflammation and resolution event being on the order of 4 weeks,
allowing us to propose that this time period corresponds to about 400 time steps in our
model (Figs. 28 and 29).
Another key feature of the muscle twitch is its refractory period, and this is borne
out in our model simulations (Figs. 28 and 31D illustrate this most clearly). Experimental
support for the existence of a refractory period in the inflammatory response is evident in
the data of Dienz et al. [25] who showed that when mice deficient in IL-6 are exposed to
influenza virus, they experience significantly higher mortality around day 9 of the
infection with fewer neutrophils recruited to the lung, compared with wild-type controls.
In both deficient and wild-type strains, however, neutrophils disappeared from the lung
around day 9. These data are consistent with the triggering of an immune response twitch
having an active duration of about 9 days. Interestingly, mice (and humans) are known to
be particularly susceptible to secondary bacterial infections following this initial immune
response to virus [26], suggesting that they enter a period of refractoriness to re-initiation
of the immune response beginning around the time when the neutrophils disappear. The
duration of the combined active inflammatory phase and the subsequent refractory phase
in our model appears to be in the order of weeks (Figs. 30 and 31). Interestingly, we have
previously observed [27] that ovalbumin challenge in mice results in cyclical levels of
Nuclear Factor-κB in bronchial epithelial cells with a period of two to six hours. While
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this is clearly far too short to correspond to the period of the inflammatory twitch, it does
suggest that frequency modulation may be a strategy employed by living organisms to
control metabolic processes manifesting over a wide range of length and time scales.
In conclusion, we have advanced a hypothesis in which a unitary self-resolving
event that we call the inflammatory twitch serves as the basis for control of the host
response to an insult from the environment. We developed an agent-based model of
allergic inflammation in the lung that exhibits key features predicted by this hypothesis,
including refractoriness to continued stimulation leading to cycles of inflammation and
repair. An implication of this hypothesis is that chronic inflammatory diseases may
reflect a failure of the inflammatory twitch to resolve toward baseline.
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CHAPTER 4: BREAKING THE INFLAMMATORY TWITCH
4.1. Introduction
Allergic airway diseases such as asthma still prove difficult for clinicians to
effectively manage [1]. The current framework for understanding these diseases is of a
type I hypersensitivity reaction in which allergen cross-links IgE-laden FcεRI receptors
on mast cells to trigger the release of mediators that signal other cells, ultimately leading
to inflammation [2]. While this framework provides an intuitively reasonable notion of
how inflammation is instigated, it does not explain how inflammation is eventually
resolved. Furthermore, it does not account for the wide range of symptomatic behavior
observed in patients. Some individuals with asthma have continual progression of
inflammatory disease [3], while others have an intermittent clinical presentation
characterized by alternating asymptomatic and symptomatic periods [4]. This suggests
that allergic inflammation should be viewed as a dynamic process that not only has a
beginning signaled by a need for host defense, but that also (hopefully) has an end that
occurs when the need for defense is no longer present.
To this end, we have recently proposed a hypothesis about the nature of the
normal allergic inflammatory response that centers on what we refer to as the
“inflammatory twitch” [5]. Specifically, we posit that stimulation with allergen sets into
motion a sequence of events that includes both factors that induce inflammation as well
as those that ultimately bring about its resolution to the baseline state. A key corollary of
the inflammatory twitch hypothesis is that there should exist a refractory period during
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which the capacity to re-instigate inflammation is suppressed, akin to the refractory
period associated with muscle twitches and neuronal action potentials. We have tested the
plausibility of this hypothesis at the alveolar-capillary interface in the lung using an
agent-based computational model that enabled us to investigate both the spatial and
temporal behaviors of the various cellular players involved [5-6]. Following calibration
against the experimental data of Tanaka et al. [7], we showed that this model can mimic
the dynamics of allergic inflammation in mice [5], supporting the notion that there is a
natural finite timescale to the normal inflammatory response.
The possible existence of an inflammatory twitch, however, immediately raises an
important question: what defects in the twitch mechanism could cause it to fail to resolve
back to baseline? Such defects might, for example, be behind the chronic inflammatory
conditions that seem to characterize allergic asthma. Investigating this question was,
accordingly, the goal of the present study. Again, a previously calibrated agent-based
computational model provides a convenient platform for addressing this question because
it serves as a virtual laboratory in which we can rapidly test the consequences of
behavioral defects in any of the cells represented in the model [5-6], hopefully helping to
focus the intent of subsequent laboratory investigation. We focus in particular on defects
that cause the twitch to either become prolonged in duration or to fail to resolve
altogether, the ultimate hope being that this will identify therapeutic targets.

4.2. Materials and Methods
4.2.1. Computational Model
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We have previously developed an agent-based computational model of the
allergic inflammatory response in an alveolar-capillary cross-section using NetLogo 4.1.3
freeware. Further details of this model are presented in a previous publication [5].
Briefly, our model of the normal allergic inflammatory response includes separate agents
representing mast cells, APCs (antigen-presenting cells, representing the combination of
dendritic cells, B-cells and macrophages), helper T-cells, T-regulatory cells, proinflammatory cells (representing the combination of neutrophils, eosinophils and other
cell types involved in causing local tissue damage), and anti-inflammatory cells

Figure 32: Mechanism for allergic inflammation in the lung. The initial cells of the response (Mast
cells and APCs) activate after encountering Particles (i.e. antigen), resulting in the indicated cascades
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(representing fibroblasts and other cells involved in tissue repair). The model is
initialized with certain numbers of these cells, each of which obeys a set of rules that
stipulates how the cell moves around in the alveolar-capillary environment, what actions
it performs and when, and how long it lives. Inflammation is triggered through the
application of a certain number of randomly placed particles (representing antigen) in the
alveolar region. The inflammatory cascade ensues as the various cell types encounter
these particles during their exploration of the environment. Figure 32 shows the scheme
Table 2: Summary of all agents and their respective rules included in the model

Cell Type
Mast Cell
(immature)
Mast Cell
(mature)

Moves Towards
Attractants

APC

Particles

Helper T Cell

Granules,
APCSignals

Pro-Inflammatory
Cell

Pro-Inflammatory
Cytokines,
Granules

T-Regulatory Cell

Pro-Inflammatory
Cytokines

AntiInflammatory Cell

Patches with
Health < 100

Particles,
Attractants

Rule
Moves preferentially to attractants, or
randomly if there are no attractants
Upon binding Particle, releases Granules for
10 time steps. Becomes inactive for user-set
time if encounters user-set number of Particles
While digesting Particle, releases APC
Signals. Becomes inactive for user-set time if
encounters user-set number of Particles
If moving towards Granules and/or APCs,
releases Pro-Inflammatory Cytokines for 10
time steps. Afterwards, if there is a strong
chemical signal on the current patch, converts
into a Pro-Inflammatory Cell
If moving towards Pro-Inflammatory
Cytokines and/or Granules, become activated
for 10 time steps. While activated, release ProInflammatory Cytokines and Attractants.
Also, subtract 5 from the health of the patch
currently on if cell has moved towards a
chemical signal, or 2 if not. At the end of
activation, the cell dies if there is a chemical
signal on the current patch
If moving towards Pro-Inflammatory
Cytokines, release Anti-Inflammatory
Cytokines
If on a patch with health < 100, add 1 to that
patch’s health parameter at each time step
120

interactions recapitulated in the model, while Table 2 lists the rules of behavior for the
different cell types. We also show a snapshot of the model during the peak inflammatory
period in Fig. 33.
The primary output of the model is a parameter we term average lung tissue
health, which is the mean value of tissue health for each patch in the model (Fig. 33). The
tissue health parameter for each patch is merely an empirical representation of the overall
local level of those various tissue abnormalities that accompany an inflammatory

Figure 33: Snapshot of the normal allergic inflammatory twitch response during a selected timepoint.
The red space represents the capillary, the blue dashed region represents the endothelial barrier, and
the patchy gray region represents the alveolar tissue, which can be tiled into patches. A darker patch
indicates a higher amount of damage that has occurred to the tissue at that location. The brown stars
represent Particles (antigen), and all the other shapes represent cells involved in the allergic response
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response in the lung, including edema formation, mucus secretion, and bronchospasm.
While these tissue abnormalities result directly from the dynamic cellular events
represented in the model, specifically representing the abnormalities themselves in the
model is beyond the scope of our study.
Tissue health is increased in the presence of anti-inflammatory cells and
decreased by pro-inflammatory cells as indicated in Fig. 31. In other words, tissue health
is simply a global measure of the integrated consequences of tissue destruction and
repair, and is given an arbitrary scale between 0 and 100. A value of 100 represents
perfect tissue health, while the degree of tissue damage is reflected in the amount by
which health has a value less than 100. Thus, a decrease in tissue health corresponds to
the inflammatory phase of the allergic response, while an increase in tissue health
corresponds to the resolution phase. Under normal circumstances, this parameter exhibits
a transient decrement in response to particle stimulation, and which is the manifestation
of the inflammatory twitch.
We have previously calibrated the dynamics of the inflammatory twitch in the
model to published experimental data in mice from Tanaka et al., [5, 7]. This enabled us
to determine that 15 time steps in the model correspond to 1 day of actual time.
Accordingly, the simulation results presented in this study are plotted against time in
days.
4.2.2. Experimental Protocol
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Table 3: List of modifications made to the agent rules of the original model

Removed all mast cells
Removed of all antigen-presenting cells
Removed of all helper T-cells
Doubled number of mast cells
Doubled the number of particles the mast cells had to encounter before becoming
desensitized
Doubled number of particles the antigen-presenting cells had to encounter before
becoming desensitized
Halved the amount of sensitization time of mast cells and antigen-presenting cells
following an encounter with a particle
Increased the lifespan of activated pro-inflammatory cells by 5x
Decreased apoptosis of antigen-presenting cells
Decreased the amount of repair performed by anti-inflammatory cells by a factor of 5
Decreased the amount of anti-inflammatory cytokines released by T-regulatory cells
Decreased the speed of movement of all T-regulatory cells by a factor of 2
Decreased the speed of movement of anti-inflammatory cells by AICs by a factor of 2

inflammatory response to particle stimulation, as in our previous study [5], but with
specific alterations to the rules assigned to the various cell types. Stimulation was
continual throughout the simulations, with 85 particles being applied to the model every
15 time steps. The original model served as the control. The interventions we investigated
fell into four general categories: 1) knockout of specific cell types, 2) alterations to the
mobility of specific cell types, 3) changes to the actions performed by specific cell types,
and 4) changes to the lifetimes or activation times of specific cell types. We did not
investigate every conceivable example of these interventions because some lead to trivial
insights. For example, knocking out all the pro-inflammatory cells would obviously
eliminate the possibility for any kind of inflammatory response at all. Similarly, knocking
out anti-inflammatory cells eliminates the possibility for any kind of tissue repair and
would automatically condemn the model to interminable inflammation. The full list of
interventions we investigated is provided in Table 3. For each intervention we ran the
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model 100 times, each time for 6000 time-steps and ensemble-averaged the resulting
simulations of tissue health.

4.3. Results
We first simulated a “normal” inflammatory twitch in response to continual
particle stimulation. The result serves as the control for our subsequent simulations, and
consists of a transient decrease in tissue health that resolves toward baseline over about 6

Tissue Health (arbitrary units)

100

99

control
mast cell KO
AP cell KO
Th cell KO

98

0

20

40

60

80

100

Days from beginning of challenge
Figure 34: The control inflammatory twitch simulated by the original model together with the
twitches produced after knocking out mast cells (mast), antigen-presenting cells (APC), and T-helper
cells (Th). Stimulation of the model by particles began at t = 0 days and continued daily throughout
the subsequent 100 days, as in Figs. 4-8. Each of the curves shown is the ensemble average of 100
simulations obtained under identical conditions, and the error bars at the peaks of each response
indicate standard errors. These errors were essentially identical in all other simulations (Figs. 4-8);
two curves are thus significantly different when they are separated by more than about 2 standard
errors
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weeks. This is the characteristic shape of the inflammatory twitch that we have
previously described [5]. We show a snapshot of the model during the peak of the initial
inflammatory response in Figure 33, and show the resulting behavior along with the
standard error at this maximal peak of inflammation in Figure 34. Continuing the
simulation for longer durations causes additional twitches to occur, with the return to
baseline between each twitch representing a refractory period during which the
inflammatory response in the model cannot be initiated.
We then applied a series of biologically motivated interventions to the model to
see how this would affect the inflammatory twitch, where our unaltered twitch model
functions as our control. We began by simulating the knock-out of certain key cell types,
achieved simply by eliminating these cells from the model. Figure 34 shows that
elimination of mast cells reduces the amplitude of the inflammatory twitch by nearly a
factor of 2, while elimination of either antigen-presenting cells or T-helper cells reduces
it by about 3-fold. Next, we discovered that the twitch is affected in only a rather minor
way by alterations in key anti-inflammatory processes in the model. Specifically, we
found that reducing the speed of movement of either the T-regulatory cells or the antiinflammatory cells has essentially no effect on the shape of the inflammatory twitch,
either in terms of its magnitude or duration (Fig. 35). Similarly unremarkable effects
were produced by reducing either the degree of tissue repair produced by anti-
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Figure 35: Effects on the inflammatory twitch of halving the speed of movement of T-regulatory cells
(Treg) and anti-inflammatory cells (AIC), relative to the control twitch

inflammatory cells or the amount of release of anti-inflammatory cytokines (Fig. 36).
By contrast, the inflammatory twitch is more sensitive to certain alterations in the
behaviors of the pro-inflammatory processes in the mode. Both mast cells and antigenpresenting cells become desensitized for a period of time after encountering a certain
number of particles [8-9]. A 4-fold increase in this number of particles for the antigenpresenting cells has a major accentuating and prolonging effect on the twitch, but a
similar increase in particle number for the mast cells has minimal effect (Fig. 37).
Doubling the number of mast cells in the model also results in a minimal effect (Fig. 37).
Also, once the critical number of particles has been encountered, both cell types remain
desensitized for a certain period of time, and halving this desensitization period for both
mast cells and antigen-presenting cells simultaneously has minimal effect on the twitch
(Fig. 37). Similarly unremarkable is the result of increasing the lifetime of the antigenpresenting cells (Fig. 38). The twitch is most profoundly affected, however, by increases
in the duration of pro-inflammatory activity in the model, which causes a major increase
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Figure 36: Effects on the inflammatory twitch of 80% reductions in the degree of repair produced by
anti-inflammatory cells (repair) and in the release of anti-inflammatory cytokines (cytokines)
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Figure 37: Effect on the inflammatory twitch of four-fold increases in the number of particles that
either mast cells (mast) or antigen-presenting cells (APC) must encounter before becoming
desensitized. Also shown are the results of doubling the number of mast cells, and of halving the
duration over which both mast cells and APCs remained desensitized for (duration)
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Figure 38: Effects on the inflammatory twitch of a 5-fold increase in the duration of activation of
pro-inflammatory cells (PIC), an 50% decrease in the probability that antigen-presenting cells will
die at each time step (APC), and the combination of a 5-fold increase in the duration of activation of
PICs with a four-fold increase in the number of particles that both mast cells and antigen-presenting
cells must encounter before becoming desensitized (Combination)

in twitch amplitude and prevents its return to baseline (Fig. 38). These effects are even
more pronounced when combined with an increased duration of activation of mast cells
and APCs (Fig. 38).
Finally, we examined the effects of applying simulated therapies to the
inflammatory response caused by increasing the duration of activation of proinflammatory cells. Knocking out mast cells has little benefit, but either knocking out Thelper cells or reducing the lifetime of pro-inflammatory cells returns the inflammatory
twitch almost back to the unaltered twitch control (Fig. 39).
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Figure 39: Effects of therapy on the exaggerated twitch caused by a 5-fold increase in the duration of
activation of pro-inflammatory cells (PIC). Interventions included knocking out mast cells (mast),
knocking out T-helper cells (Th), and halving the probability of survival of the pro-inflammatory
cells at each time step (survival)

4.4. Discussion
One of the benefits of utilizing agent-based modeling is that it allows us to
simulate the spatiotemporal behavior of a complex system, such as a community of
inflammatory cells, in order to discover emergent dynamic behavior that would be
difficult to reveal in any other way. This was the motivation for our original study in
which we presented the inflammatory twitch hypothesis [5], and which we continue in
the present study by investigating the consequences of certain interventions on the twitch
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profile. Of course, the validity of any of the conclusions we reach depends critically on
the extent to which our model captures the important aspect of reality, and this is always
open to question even if we can demonstrate that the behavior of the model resembles
experimental data [7]. To the extent that the model does capture reality, however, our
present study reveals some interesting and not always expected behavior that may suggest
approaches to the treatment of chronic inflammatory diseases such as allergic asthma.
Our major goal in this study was to see if we could manipulate the model so as to
cause the twitch to become increased in magnitude and/or extended in scale. The latter
effect, in particular, would presumably then constitute a model of chronic inflammation,
a condition that is still poorly understood and frequently difficult to treat. We found that
many of the interventions we tried had relatively little effect on the inflammatory twitch.
In fact, most individual interventions, such as cell knockout, impaired migration, altered
lifespan, or impaired activity of a single cell type, still resulted in twitches with cycles of
damage and repair that in many cases were little different from the control. This finding
supports our notion that the inflammatory twitch is a general mechanism used by the
body to control the host response; such a control mechanism would need to have some
degree of resilience to system defects in order to be robust. On the other hand, direct
manipulation of the pro-inflammatory cells in the model had a very large effect on the
twitch, suggesting that this is where we might focus our attention in terms of devising
therapies. Even so, it is instructive to consider the biological significance of all our
simulated interventions, regardless of their effect size.
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Figure 34 shows the effects of knocking out cells involved in the initiation of the
inflammatory response. We show the standard errors at the maximal point of the initial
inflammatory response on each curve to show there is significant difference between the
unaltered twitch (our control) and the interventions. Both the mast cells and antigenpresenting cells release chemical signals that initiate the inflammatory response, while Thelper cells amplify these signals to draw pro-inflammatory cells (the only cell type in the
model that directly damages tissue) to the site of injury. Knocking out T-helper cells in
our model can be thought of as simulating the effect of corticosteroid administration [10],
and leads to a substantial decrease in twitch amplitude relative to the control twitch. By
contrast, knocking out mast cells has a relative smaller effect on the twitch, which is in
keeping with the observed benefits of sodium cromoglycate administration relative to
steroid [11-12] and the fact that mast cells are relatively sparse in the lung [13]. Knocking
out antigen-presenting cells has an effect similar to that of T-helper cells, which may be
related to the fact that there are relatively more antigen-presenting cells that mast cells in
the model as observed in the lung [8, 13]. Nevertheless, the overall shape and time
course of the inflammatory twitch remains similar in each knock out, which is perhaps
not something we might have guessed a priori.
Also somewhat surprising is the finding that reducing the mobility of cells
involved in the resolution of inflammation by a factor of two only leads to subtle changes
in the inflammatory twitch (Fig. 35). Slowing the anti-inflammatory cells directly
responsible for repairing lung tissue marginally attenuates the response, while slowing
the T-regulatory cells shifts the twitch to a slightly earlier peak. In both cases, however,
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there is little change relative to the control twitch, which suggests that the rate of
resolution of inflammation is not limited by the speed with which the reparative cellular
machinery is able to move to a site of inflammation. Another possibility for the ratelimiting factor in the resolution phase is the degree of anti-inflammatory activity that
takes place at the site of injury once the reparative machinery has arrived. We tested this
by making substantial reductions in both the amount of chemical signals secreted by Tregulatory cells and the amount of repair performed at each time step by antiinflammatory cells. Again, and somewhat to our surprise, we found relatively minimal
effects in both cases (Fig. 36). The inflammatory twitch in our model thus exhibits a
degree of resilience to changes in the system that produces it, which could be viewed as
of benefit to the organism given the importance of maintaining a viable host response.
We eventually found an intervention that does have a significant effect on the
inflammatory twitch, namely an increase in the duration over which antigen-presenting
cells remain activated after encountering particles. Our model maintains these cells in the
active state (i.e. releasing signals) until they encounter a critical number of particles, at
which point they become quiescent for a period of roughly six months [5, 8-9]. When the
critical number of particles for the antigen-presenting cells is increased 4-fold, we find
that the twitch is nearly doubled both in amplitude and duration (Fig. 37). On the other
hand, applying the same intervention to mast cells has relatively little effect on the twitch
amplitude, perhaps because of the sparseness of this cell type in the model. Interestingly,
doubling the number of mast cells has a minimal effect on the twitch (Fig. 37). Also
interestingly, halving the duration over which both antigen-presenting cells and mast cells
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remain quiescent also has little effect on the twitch amplitude but it leads to a second dip
in tissue health before the end of the simulation period (Fig. 37). We suspect that this
represents a reduction in the refractory period of the twitch due to the earlier re-activation
of the mast cells (the other simulations also exhibit secondary dips, but these occur after
the periods of time shown in the figures). In any case, these findings thus suggest that
deactivating antigen-presenting cells (which we assume to be chiefly comprised of
basophils and dendritic cells) might be an effective therapeutic approach for chronic
inflammatory disease, but we are not aware of any therapies that operate via this
mechanism.
By far the largest effect on the inflammatory twitch, however, was achieved in
our model by manipulating the cells that actually create tissue damage: the proinflammatory cells (assumed to represent chiefly neutrophils and eosinophils). Increasing
their lifespan following activation by a factor of 5 led to an enormous increase in the
amplitude of the inflammatory twitch, eventually returning to a baseline health value that
was far less than that observed in the unaltered twitch (Fig. 38). This finding is consistent
with the well-documented existence of abnormally long-lived neutrophils and eosinophils
in chronic allergic inflammatory diseases such as asthma [14-16]. The effect received a
further substantial boost if both anti-inflammatory cells and mast cells were able to
encounter a 4-fold increase in the number of particles before becoming desensitized. By
contrast, simply increasing the survival of the antigen-presenting cells had little effect
(Fig. 38).
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The results shown in Figure 38 suggest that impaired apoptosis of neutrophils and
eosinophils might be a key pathogenic mechanism in chronic inflammatory disease. An
obvious question, then, is what therapies might cause the resulting exaggerated
inflammatory twitch to revert back to normal. To investigate this question we applied a
number of interventions to the model in which a 5-fold increase had been applied to the
duration of activation of pro-inflammatory cells (i.e. using the PIC curve in Fig. 38 as the
starting point). We found that removing the mast cells from the model had only a slight
ameliorating effect on the exaggerated inflammatory twitch, but that knocking out the Thelper cells brought the twitch almost back to its control configuration (Fig. 39), which
fits with the relatively greater efficacy of corticosteroids compared to cromolyn in
reversing allergic inflammation. Most intriguing, however, was the finding that
decreasing the survival of pro-inflammatory cells had an effect that was comparable in
magnitude to that of T-helper cell elimination, and in fact caused the twitch to resolve
back closer to the fully healthy state (Fig. 39). These results suggest that therapies aimed
at increasing apoptosis in neutrophils and/or eosinophils might be efficacious in treating
chronic allergic asthma [14-17].
As fascinating as these results might be, however, we must bear in mind that they
are all based on a computational model that is itself the embodiment of a large number of
simplifying assumptions made in the interests of computational and conceptual
tractability as we have discussed previously [5]. For example, we assume that the
alveolar tissue environment is currently homogenous and isotropic, whereas in fact the
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various alveoli of the lung can be quite heterogeneous with physical and chemical
anisotropies that may constrain the directions of cell movement [18-19].
A related assumption is that cytokines and other chemical signals diffuse at the
same linear rate through the environment at each time step. Yet in reality, different
chemical signals diffuse through the environment at different rates [20], and may diffuse
in non-linear fashion [21-22]. Our model also ignores any functional differences between
the various cell types involved in the onset of inflammation, including neutrophils and
eosinophils, by lumping them all into a single pro-inflammatory cell type. Similar coarsegraining is applied to the various cells involved in the resolution of inflammation. The
rationale behind these various assumptions is that we have captured the most important
features of the cellular system involved in the inflammatory response, but this always
remains open to question and underlies our conclusions.
Finally, we should point out that while the singular advantage of agent-based
modeling relates to the ease with which the spatiotemporal dynamics of a complex
system can be investigated, we have taken limited advantage of the spatial aspect in the
present study. Figure 33 shows the configuration of the model during the peak of the
inflammatory response under control conditions. The patchy appearance of the alveolar
tissue damage (indicated by the darkened regions) reflects both the stochastic nature of
the simulation as well as the fact that cytokine concentrations are not uniform and cells
move according to directed diffusion from their source in the vasculature, yet we only
consider on a global tissue health parameter that integrates this spatially distributed
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damage. However, this model can be easily extended to include spatially heterogeneous
properties throughout the alveolar region when the inclusion of this kind of detail
becomes necessary. The present model thus represents a first foray into the computational
modeling of the allergic inflammatory response in the lung.
In summary, we have presented a computational model of the allergic
inflammatory response as an in silico laboratory for testing hypotheses about the nature
of the allergic inflammatory response, focusing in particular on the factors that might
cause the response to become pathologically accentuated and/or prolonged. Our model
predicts what we term the inflammatory twitch as an emergent behavior arising from the
spatiotemporal interactions between the major cell types involved, and shows that this
inflammatory twitch is rather robust to a number of individual system defects.
Nevertheless, the model also shows that the twitch can be significantly accentuated and
prolonged by factors that increase the activity and lifetime of pro-inflammatory cells, and
that interventions simulating the effects of cromolyn and corticosteroid administration
can be effective in returning the twitch toward a more normal configuration. Perhaps
most interestingly, our model also suggests that therapies directed at increasing the rate of
apoptosis of inflammatory cells, such as activated neutrophils and eosinophils, could be
particularly efficacious in treating chronic inflammatory airway disease.
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CHAPTER 5: DISSECTING THE TWITCH
5.1. Introduction
The inflammatory response to a noxious stimulus is crucial for survival, and is
initiated by a cascade of events beginning with the recognition of the stimulus by sentinel
cells.

Equally important for health, however, is the resolution of the inflammatory

response when it is no longer needed. Indeed, failure of the inflammatory response to
resolve may underlie a variety of chronic diseases. This raises the fundamental question
of how the duration of the inflammatory response is controlled. In particular, it is difficult
to imagine the existence of some agent in the body with the capacity to decide when
inflammation is no longer necessary, so how is the inflammatory response turned off?
As a possible response to this question, we recently postulated that inflammation
is subject to the same control strategy as skeletal muscle, namely through the repetitive
invocation of self-limiting unitary events that, in the case of muscle, are known as
twitches [1]. We hypothesized that the inflammatory equivalent, which we term the
inflammatory twitch, continues to be invoked so long as the allergic stimulus is present.
This allows an ongoing inflammatory response stream to be maintained while it is
needed, but ensures that the response will automatically dissipate when the stimulus
disappears. Of course, a skeletal muscle twitch lasts in the order of 100 ms while an
inflammatory response would have to last for much longer, but the two systems may still
have strong formal similarities in control structure despite their huge differences in
timescale.
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We previously used an agent-based computational model in a proof-of-concept
study to show that a twitch-like event can, in principle, arise with respect to allergic
inflammation in the lung [1]. We then used the model to perform a series of in silico
experiments that explored how the inflammatory twitch could potentially fail to resolve
[2], the notion being that such failure might explain the chronic inflammation
characteristic of allergic asthma. Nevertheless, experimental data in support of the
inflammatory twitch hypothesis remain somewhat sparse. In particular, while there is
some evidence that the normal allergic inflammatory response is indeed self-limited [34], there has yet to be a comprehensive test of another key prediction of the hypothesis,
namely that the response should be accompanied by a refractory period during which it
cannot be reinitiated by continued antigen stimulation. Accordingly, the goal of the
present study was to perform a detailed examination of the time-course of the
components of the allergic inflammatory response in the lung and to determine if any of
these components exhibit periods of refractoriness. We performed this investigation in
ovalbumin-sensitized mice that were challenged with aerosolized ovalbumin for varying
durations and then re-challenged after varying rest periods.

5.2. Experimental Design
Our studies conformed to the National Research Council Guide for the Care and
Use of Laboratory Animals and were approved by the University of Vermont’s
Institutional Animal Care and Use Committee (IACUC).
5.2.1. Antigen Sensitization and Protocol
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Figure 40: Experimental design. All groups of mice were given IP injections of OVA and alum on day
-14 and Day -7 relative to the beginning of the challenge period. All groups were given a single recall
challenge on Day 31. Open circles represent challenge with saline. Closed circles represent challenge
with 1% OVA

We studied 104 female BALB/cJ mice at 7-8 weeks of age (Jackson Laboratories)
separated into five groups: Saline-3 (16 mice), Saline-31 (8 mice), OVA-3 (24 mice),
OVA-31 (8 mice), OVA-14 (24 mice) and OVA-21 (24 mice). Numbers after Saline or
OVA correspond to the number of consecutive days for which the mice were challenged.
The experimental protocol is outlined in Figure 40. All mice were initially sensitized with
intraperitoneal (IP) injections of 0.1 mL containing 20 µg ovalbumin (OVA) in
phosphate-buffered saline suspended in 2 mg of alum (ThermoFisher Scientific) on Day 20 and Day -6. The different animal groups were then subjected to different regimens of
daily OVA challenge, each regimen beginning on Day 1 as indicated in Figure 40. A
daily challenge consisted of placing the animals in a closed chamber for 30 minutes
within which they were exposed to aerosols of either 1% OVA in phosphate-buffered
saline or to phosphate-buffered saline.
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The Saline-3 and OVA-3 groups were challenged for the shortest duration of 3
consecutive days. Mice in Saline-3 were exposed to nebulized saline and then divided
into two subgroups each containing 6-8 mice. One subgroup was studied (see below) one
day after the 3 challenges (i.e. on Day 4). The other subgroup was maintained without
further challenge for another 28 days, subjected to a saline recall exposure on day 31, and
then studied a day later. Mice in OVA-3 were treated identically to the Saline-3 animals
except that they were exposed to nebulized OVA instead of saline.
The Saline-31 and OVA-31 groups were challenged for the longest duration of 31
days. Mice in the Saline-31 group underwent daily exposure to nebulized saline (Day 1 to
Day 31) and were studied a day later (i.e. on Day 32). Mice in OVA-31 were treated
identically to Saline-31 animals except that they were exposed to OVA instead of saline.
The OVA-14 and OVA-21 groups were challenged with OVA for the
intermediate durations of 14 and 21 days, respectively. Mice in OVA-14 were divided
into two subgroups. One subgroup was studied one day after the final challenge (i.e. on
Day 15). The other subgroup was maintained without challenge until Day 31 at which
point they received a recall challenge with OVA and then were studied a day later (i.e. on
Day 32). Mice in OVA-21 were treated similarly except that their initial sequence of
daily challenges with OVA ended on Day 21.
5.2.2. Study Procedures

144

Lung Physiology: Mice were anesthetized with an intraperitoneal injection of
sodium pentobarbital (90 mg/kg), tracheostomized, and cannulized. They were then
attached to a computer-controlled mechanical ventilator (Flexivent, Scireq, Montreal,
Quebec, Canada), paralyzed with an IP injection of pancuronium bromide (0.8 mg/kg),
and administered regular ventilation at 200 breaths/min against a positive-end-expiratory
pressure (PEEP) of 3 cmH2O while EKG was monitored to ensure depth of anesthesia.
The forced oscillation technique was used to measure respiratory impedance (Zrs) over
the frequency range from 1 to 20.5 Hz using a 2 s broadband perturbation in volume
applied by the Flexivent exactly as we have done in a number of prior studies [5-7]. Each
measurement of Zrs was fit to the constant-phase model [6, 8]. We used two of the best-fit
parameter values of the constant-phase model as our outcomes variables: 1) the
Newtonian resistance (Rn) of the lung, which accurately estimates airway resistance [9]
and 2) lung stiffness (H), which is essentially equivalent to lung elastance [6]. Two
baseline values of Rn and H were obtained in this way. We then exposed each animal to
an aerosol of saline, delivered for 10 s via the inspiratory line of the Flexivent, and then
determined Rn and H every 10 s for 3 minutes for a total of 18 measurements of each
parameter. This sequence was then repeated replacing the saline aerosol with aerosolized
methacholine at a concentration of 12.5 mg/ml. Airway responsiveness to saline and to
methacholine was determined from the averages of the 18 measurements of Rn and H
made following each challenge.
Broncho-alveolar

lavage:

Following

the

end

of

the

AHR

protocol,

bronchoalveolar lavage fluid (BALF) was gathered by lavaging the lungs with 1 mL of
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saline. This lavage fluid was centrifuged at 600 g at 10ºC for 10 minutes and the resulting
cell pellet was re-suspended in saline. Half of this sample underwent cell counting using
an Advia 120 Hematology System (Bayer Healthcare, Tarrytown, NY) from which total
cell numbers were counted. The other half of the sample was used to make cytospins that
were stained and from which differential cell types were identified.
Cytokine Analysis: Following the gathering of BALF, left lobes of the mouse
lungs were dissected and ground to a fine powder using a liquid nitrogen-chilled mortar
and pestle, and subsequently resuspended and vortexed in 400 µL of saline. The
suspensions were transferred into separate QiaShredder spin columns (Qiagen) and
centrifuged at 11,000 rpm at 10ºC for 10 minutes. Flow-throughs were then transferred to
clean microcentrifuge tubes, while avoiding the pellet on the bottom, and were stored at 80ºC until analysis. Following thawing on ice, total protein concentrations were assessed
using a Bio-Rad (Bradford) assay, with relative cytokine concentrations assessed using a
custom R&D Systems mouse cytokine panel and a Luminex instrument, according to
manufacturer’s instructions.
Statistics: Inter-group comparisons were made using paired t-tests or ANOVA,
with post-hoc Bonferroni corrections for multiple comparisons as appropriate. Statistical
significance was taken as p < 0.05.

5.3. Results
5.3.1. Twitch Time Course
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Figure 41: Closed circles show concentrations of cytokines measured in the left lobes of lungs of mice,
characterized 24 hours following the last day of daily antigen challenge, and on day 31 immediately
preceding and following recall challenge with OVA: A) GM-CSF, B) KC, C) IL-5, D) IFN-γγ, and E)
IL-10. Open circles show corresponding control measurements made in control mouse lungs 24 hours
after 3 days of saline and a recall challenge with saline on day 31. All points are reported as means ±
standard errors. * indicates a value statistically higher than Control 1, ** indicates a value
statistically higher than Control 2, and *** indicates a value statistically higher than the other three
values in OVA-challenged animals
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Figure 42: Closed circles show concentrations of cytokines measured in the left lobes of mouse lungs
24 hours following the final daily OVA challenge, and on day 31 immediately following recall
challenge: A) IL-4, B) IL-17, C) IL-3, and D) IL-6. Open circles show corresponding control
measurements made 24 hours after Day 3 of saline challenge (Control 1: left-hand point) and one day
after saline recall challenge (Control 2: right-hand point). Points represent mean ± standard error. *
indicates statistically higher than Control 1. ** indicates statistically higher than Control 2

Figure 41 shows that the temporal patterns of the lung cytokines over the 31 day
study period could be separated into two groups. GM-CSF, KC and IL-5 levels in the
OVA-challenged animals peaked transiently at Day 3 where they were significantly
different from control (Figs. 41A-C). Afterwards, GM-CSF and IL-5 levels fell below at
least one of the groups challenged with saline (control). KC levels also dropped after Day
3 but remained higher than both control measurements, and by Day 31 IL-5 was at a
statistically significant but physiologically meaningless difference from baseline. In
contrast, IFNγ and IL-10 levels in the challenged animals peaked transiently at Day 21
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Figure 43: Closed circles show various cell types measured in BALF from mouse lungs 24 hours after
3, 14, 21 and 31 days of daily OVA challenge: A) total leukocytes, B) eosinophils, and C) neutrophils.
Open circles show corresponding control measurements made 24 hours after 3 days (Control 1: lefthand point) and 31 days (Control 2: right-hand point) of saline challenge. Points represent mean ±
standard error. * indicates statistically higher than Control 1. ** indicates statistically higher than
Control 2
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but were statistically indistinguishable from control at Day 3 and Day 31 (Figs. 41D and
E). IL-4, IL-13 and IL-17 did not rise significantly above control in response to OVA
(Figs. 42A-C), while IL-6 levels fell to control levels at Day 14 before rising again at Day
21 and Day 31 (Fig. 42D).
BALF total leukocytes and eosinophils for the OVA-treated mice were
significantly higher than control mice at all time points measured from Day 3 to Day 31,
both peaking at Day 14 (Figs. 43A and B). In contrast, neutrophil levels at Day 3 were
not significantly different between OVA-treated and control animals but rose thereafter in
the treated group to become significantly different from at least one control out to Day 31
(Fig. 43C).
The lung mechanics parameters Rn and H in response to Mch were significantly
elevated in the OVA-treated mice compared to controls at all measured time points from
days 3 to 31. Rn in the treated animals peaked at day 21 (Fig. 44A) while H peaked at day
14 (Fig. 44B).
5.3.2. Refractory Period
The existence of a refractory period in allergic inflammation is indicated by the
need to wait for a certain duration of time following cessation of OVA challenge before
inflammation can be re-instigated by a recall challenge. Figures 44A-C show that that
GM-CSF, KC and IL-5 all exhibited significant increases in their levels with wait periods
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Figure 44: Closed circles show lung mechanics parameters measured in mice measured 24 hours
after 3, 14, 21 and 31 days of daily OVA challenge: A) Rn, and B) H. Open circles show
corresponding control measurements made 24 hours after 3 days (Control 1: left-hand point) and 31
days (Control 2: right-hand point) of saline challenge. Points represent mean ± standard error. *
indicates statistically greater than Control 1. ** indicates statistically greater than Control 2. ***
indicates statistically distinct from the other three measurements in the OVA-challenged animals
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Figure 45: Concentrations of cytokines in the left lobes of lungs of mice measured 24 hours following
3, 14 and 21 days of OVA challenge, and both immediately preceding and following recall challenge:
A) GM-CSF, B) KC, C) IL-5, D) IFN-γ, and E) IL-10. Control measurements were made 24 hours
after 3 days of saline challenge and after a recall challenge with saline on day 31. Points represent
mean ± standard error. * indicates significant increase following the recall challenge. ** and ***
indicate significant increases following removal of an outlier from the post-recall group and prerecall groups, respectively
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of 10, 17 and 28 days after the end of the initial period of challenge, although the
biological significance of the increase in GM-CSF at 28 days appears minimal. These
findings suggest that the refractory period for these cytokines is no longer than 10 days.
In contrast, IFNγ and IL-10 only increased significantly following a wait period of 28
days (Figs. 45D and E). Interestingly, for GM-CSF, IFNγ and IL-10 the gain in cytokine
levels decreased as the wait period increased, whereas for IL-5 the gain increased with
the wait period duration.
Variability also occurred with respect to the cellularity of the BALF. The number
of total leukocytes and neutrophils were only increased by a recall challenge when it was
given 28 days after the end of the initial challenge sequence, but not when the wait time
was 10 or 17 days (Figs. 46A and C), indicating that their refractory periods are greater
than 17 days. In contrast, eosinophils showed no significant increase in response to recall
challenges at any of the three wait periods (Fig. 46B), indicating that the eosinophil
refractory period is more than 28 days in length.
Variable refractory periods were also observed for the parameters of lung
mechanics. Waiting 17 days before initiating recall challenge resulted in a statistically
significant increase in Rn although it was not until 28 days that this increase was
biologically significant (Fig. 47A). In contrast, H did not increase significantly with
recall challenge after any of the wait times investigated (Fig. 47B). These findings thus
suggest that the refractory period for lung hyperresponsiveness in terms of tissue
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Figure 46: Numbers of cells measured in BALF from mouse lungs 24 hours following 3, 14 and 21
days of OVA challenge, and both immediately preceding and following recall challenge: A) total
leukocytes, B) eosinophils, and C) neutrophils. Control measurements were made 24 hours after 3
days of saline challenge and after a recall challenge with saline on day 31. Points represent mean ±
standard error. * indicates significant increase following the recall challenge
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Figure 47: Measurements of lung mechanics parameters in mice 24 hours following 3, 14, and 21
days of OVA challenge, and both immediately preceding and following recall challenge: A) Rn, and
B) H. Control measurements were made 24 hours after 3 days of saline challenge and after a recall
challenge with saline on day 31. Points represent mean ± standard error. * indicates significant
increase following the recall challenge
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elastance is longer than 28 days while in terms of airway resistance it is less than or equal
to 17 days.
5.4. Discussion
The findings of the present study show that each of the components involved in
the allergic inflammatory response is part of a team that together produces a self-limited
dynamic inflammatory response. The individual cell types (Fig. 43) and their cytokine
products (Figs. 41 and 42) exhibit varying dynamics over the course of a month from the
beginning of continual antigen challenge, but collectively they are responsible for the
dynamics of the physiologic phenotype evident in Fig. 44. Our results go further than
simply dissecting the components of the transient response to antigen, however, by
demonstrating clear evidence of a refractory period in the dynamic phenotype (Fig. 47) as
well as in some of its components (Figs. 45 and 46). A refractory period is key to any
form of self-limited response because re-initiation of the response must be precluded for
at least some period of time to allow it to be forced to resolve back to baseline. Evidence
for the existence of such a refractory period in the allergic inflammatory response is seen
in previous studies that showed both that continual stimulation with antigen for 30 days
eventually leads to non-responsiveness [10] and that re-stimulation with antigen after a
rest period elicits another vigorous response [4]. In fact, the dissipation of an allergic
response in the face of continued antigen challenge is well-known to the immunology
community as the phenomenon of local inhalational tolerance [11]. The inflammatory
twitch hypothesis provides a teleological basis for the phenomenon of tolerance by
showing how it potentially solves the thorny control problem presented by the need to
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automatically turn off a response that would be harmful if it persisted beyond when it is
needed, but for which there is no obvious “off switch”.
We note that while there are clear signs of twitch-like behavior in our data, this
does not apply to every relevant player in the allergic inflammatory response. An
exception is the response pattern exhibited by neutrophils, which showed no signs of
resolving to baseline (Fig. 43C). Also, total cell numbers (Fig. 43A), Rn (Fig. 44A), and
KC (Fig. 41B) all peaked in their responses but remained at elevated plateaus out to Day
31, and some of the cytokines did not differ in their time courses relative to control (Fig.
42). There are several possible ways to interpret these findings. One is that those
quantities that did not return baseline eventually would have if we had continued the
experiment for long enough, which would mean that the inflammatory twitch lasts longer
than the one month period over which we investigated it. Another possibility is that there
are aspects of the response to continual antigen stimulation that are maintained
indefinitely, and which would thus not conform to the twitch hypothesis. Indeed, such
persistence is what one would expect of anything related to immune memory, so while
those aspects of the allergic inflammatory response that need to be transient might be
controlled in a twitch-like fashion, there are other aspects that need to remain active for
the health of the organism. Also, it is possible that some components of the inflammatory
response are capable of summation in the same way that force can summate in skeletal
muscle. Thus, the refractory period in the allergic inflammatory twitch might be defined
by events that resolve more quickly than the physiological phenotype shown in Fig. 43,
such as the group of early cytokines that appear to have a refractory period of 10 days or
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less (Fig. 40A-C), which would potentially allow the methacholine responsiveness
phenotype to summate.
Putting these results together generates an overall picture of the allergic
inflammatory response. While the complete response may take more than 31 days to
manifest fully, within the 31 day window that we examined in the present study there are
a number of distinct events that wax and wane over different time scales. First, there is an
initial transient phase of early cytokines that peaks at Day 3 followed by responses in
eosinophils and lung tissue stiffness that peaks at Day 14. Then there is a leukocyte peak
between Day 14 and Day 21 that is followed by both the later cytokines and airway
resistance, both peaking at Day 21. Drawing on our analogy with the skeletal muscle
twitch, these various events are similar to the components of the muscle twitch that
include the early action potential followed soon after by calcium influx and then later by
force development. In other words, the muscle twitch and inflammatory twitch are both
composed of a sequence of events in which the early events trigger the later events until
there is eventual resolution back to baseline. It should be noted, however, that this may
paint a somewhat oversimplified picture of the inflammatory twitch because its various
cell and cytokine components do not function in isolation but rather operate as part of
networks. The time-course of a particular component may thus reflect its changing
environment as much as, or even more than, its own intrinsic dynamics.
An interesting question raised by our results is why some cytokines peak at Day 3
(GM-CSF, KC and IL-5 in Figs. 41A-C) while others peak at Day 21 (IL-10 and IFNγ in
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Figs. 41D and E). IFNγ and IL-10 are known to be associated with Th1 and T-regulatory
cells, respectively [12-14], while IL-5 is associated with Th2 cells [15]. GM-CSF and KC
are also known to be associated with the activation of dendritic cells and the recruitment
of neutrophils [16-17], cells also involved in the early phase of the allergic response. One
possibility, therefore, is that the cytokine picture in Fig. 40 indicates a switch from an
early Th2-mediated inflammatory phase to a later Th1-mediated resolution phase that
involves T-regulatory cells. This is consistent with other studies showing that in mice
allergic to Aspergillus fumigatus, interventions that target the Th2-mediated phase of the
response result in decreased levels of not just IL-5, but also IFNγ, IL-4, IL-13 and
lymphocytes (specifically CD4+ T-cells) [18]. Interestingly, this also reduced airways
hyperresponsiveness, although others have shown in mice allergic to OVA that Th1
cytokines do not induce airway hyperresponsiveness [19].
The inflammatory twitch hypothesis raises the possibility that pathologic
alterations in some of the molecular and/or cellular events involved in the allergic
inflammatory twitch could transform it into a non-resolving event. Such a transformation
might correspond to the chronic inflammation characteristic of allergic asthma. We
investigated this possibility theoretically in a previous study by manipulating our
computational model in ways corresponding to plausible biological abnormalities [2].
Many of these manipulations, such as altering the amounts of chemical signals released
by cells, knocking out certain cell types, and changing the speed of movement of cells
within the tissue environment, did relatively little to change inflammatory twitch
dynamics. However, increasing the life span (i.e. delaying apoptosis) of pro159

inflammatory cells in the model had a powerful effect on extending the magnitude and
duration of simulated inflammation [2]. Interestingly, inflammatory cells have been
documented to have longer lifespans in individuals with airway disease [20-23]. The
results of the present study suggest that this might apply particularly to eosinophils (Fig.
42).
Finally, we must view the findings of our study within the context of its
limitations. Perhaps most significant is the limitation placed by our study design on our
ability to resolve the various features expected of a twitch-like response. We chose a
design aimed at obtaining as much information as possible about the inflammatory twitch
from a limited number of animals, but this gave far from complete coverage of all the
possibilities. For example, we are not able to distinguish between the inflammatory
effects due to length of antigen challenge from those of a rest period prior to recall
challenge because challenge duration and rest duration varied oppositely in our study
design (Figure 41). We also employed only a single day of recall challenge, allowing us
to study only the most rapid response features inflammatory twitch that may differ from
those of a more extended recall challenge. Fully characterizing the inflammatory twitch
in all its aspects would require that our experiments be repeated over a significantly
longer time scale than one month, and that many more configurations of challenge and
rest be examined. This would have required a large number of additional mice, and we
studied 104 mice over a total time of a month and a half as it was. Questions about the
dynamics of the allergic inflammatory twitch thus remain. Nevertheless, we were able in
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the present study to add significantly to our understanding of these dynamics, and to
place this understanding within the framework of the inflammatory twitch hypothesis.
In conclusion, we have provided experimental evidence consistent with our
allergic inflammatory twitch hypothesis. Specifically, we have demonstrated transient
behavior in many of the cells and cytokines involved in the response as well as its
phenotypic manifestation in terms of lung function. These findings support the notion
that the allergic inflammatory twitch in normal mice lasts in the order of one month. We
have also demonstrated clear evidence of refractory periods in many of these components
of the response, some as short as only a few days. These findings corroborate the notion
that control of the host response employs frequency modulation in the same way that
control is exerted over muscle force, neural signaling, and indeed a host of other
biological processes that are initiated by single instigating events. The inflammatory
twitch hypothesis thus provides a general mechanism to explain how inflammation is
controlled in a normal healthy individual, and also suggests how it might become
aberrant in individuals who develop chronic inflammatory diseases such as allergic
asthma.
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CHAPTER 6: INFERRING STEM CELL BEHAVIOR
6.1. Introduction
One of the hopes of stem cell research is being able to grow entire organs ex vivo
for use in clinical transplantation and as model systems for study. An approach that may
hold promise for the engineering of complex organs is the use of decellularized scaffolds
devoid of cells and antigenic material that are then seeded with autologous stem cells in
the hope that a fully functional organ will eventually develop [1, 2]. In the case of the
lung, as with many organs, this promise remains far from realized [3, 4]. Indeed, stem
cell research has thus far been essentially empirical, leading some to refer to these
investigations as “modern alchemy” [1]. One possible reason for the current state of
affairs is an almost complete lack of predictive modeling tools with which to guide the
direction of investigation.
The ability to predict the course of tissue regeneration must rely on a knowledge
of the rules governing how relevant cell types behave in the various situations they will
encounter during the regeneration process. These rules indicate how each cell influences,
and is influenced by, its neighboring cells and the surrounding microenvironment in
which it finds itself [5, 6]. Armed with such rules one could, in principle, simulate the
process of tissue regeneration to identify promising scenarios before trying them
experimentally, thereby greatly increasing the efficiency of the search for effective
regeneration strategies. The computational approach known as agent-based modeling [7,
8, 9, 10] seems perfectly suited to this endeavor. However, such modeling relies on
166

knowledge of the rules of cell behavior, about which we currently know little. On the
other hand, agent-based modeling might also be of assistance in determining these rules
through comparison of model predictions to experimental data.
Although sophisticated agent-based models have been applied to a variety of
cellular systems, including the growth and maintenance of skin [11] the use of
mesenchymal stem cells (MSCs) to generate bone [12], these models have yet to be
applied to the study of stem cells in the lung. Accordingly, toward this end, we
investigated the engraftment patterns of two different cell types relevant to the
regeneration of lung tissue following their seeding onto decellularized lung scaffolds.
Simultaneously, we employed an agent-based computational model to simulate
engraftment patterns based on simple sets of behavioral rules governing how cells move,
when they divide, and when they die. By determining which rules more closely
recapitulated experimental observations we are able to infer those that plausibly might
differentially regulate the behavior of the two cell types.

6.2. Methods
6.2.1. Computational Model
We created a computational model to study two Hypotheses, termed Hypotheses 1
and 2, respectively, regarding the behavior of stem cells on these decellularized scaffolds.
Both hypotheses are motivated by experimental observations regarding two
representative cell types investigated for seeding decellularized lung scaffolds: C10
epithelial cells, an immortalized mouse type 2 alveolar epithelial cell line, and bone
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marrow-derived MSCs [13, 14]. From previous experiments we know that C10s tend to
mostly be present at the tissue periphery at later time points [13]. Given the nature of
cells to move via chemotaxis, this suggests that there is some substrate incorporated into
the scaffold with a concentration that is highest at the borders of the tissue slice and
decreases progressively toward the center. The identity of this substrate is currently
unknown, but possibilities include oxygen or extracellular matrix components such as
fibronectin and laminin that may be distributed preferentially toward the periphery of the
alveolar tissue [15].
We used NetLogo 4.1.3 freeware [9, 10] to design a 3-dimensional agent-based
model of a decellularized scaffold environment seeded with cells that can attach to and
proliferate over it. The environment of the model represents an initially decellularized
lung scaffold, and is composed of a set of contiguous cuboidal patches, each
characterized by local variables that define its properties. The cells applied to the model
scaffold are represented by discrete agents capable of moving around from patch to patch
according to stochastic rules that define the likelihood of their rates and directions of
movement.

Figure 48: Diagram illustrating the location of a cell’s neighbors. The cell (black ball) is at the center
of the cube, and the 26 white balls illustrate the location of its neighbors in 3-D space
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At every time point, only one cell can exist on each patch, meaning a motile cell
cannot move into the same location as an already engrafted cell. However, additional
rules allow the cells to interact with neighboring agents and the patches that they come
into contact with. Each cell has up to 26 neighbors as illustrated in Figure 48. These
interactions may involve any putative biological effect such as the alteration of the
environment by the secretion of chemical signals, or a direct effect of one cell on another.
In particular, we assume engrafted cells increase the substrate concentration of the patch
they are on by an arbitrary value of 1. If the cell dies, then the patch substrate
concentration is decreased by 1.
We represent the environment of the lung scaffold as 32 x 32 x 32 individual
cubic patches, with the environmental border representing the edges of the scaffold. (The
environment size and the spacing between the patches are constraints set by the NetLogo
software.) Each patch has a local variable whose value represents the numerical
concentration of a bioactive substrate that influences cell behavior (see below) such that

the substrate concentration has a value c =

20 x 2 + y 2
21.2

for any set of (x, y, z)

coordinates, as the x, y and z axes range from -16 to 16 (in arbitrary distance units). While
this formula is arbitrary, it creates an environment where in any x-y plane, the lowest
substrate concentration (c = 0) is at the center (x = 0, y = 0) while the highest
concentration is at the borders, thereby creating a substrate gradient and thus an impetus
for cell movement and exploration of the environment. The cells are motile, and so move
in 3 dimensions from one patch to another at each time step.
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The scaffold was seeded at t = 0 with 30,000 randomly placed identical agents
(cells) because this gave a seeding density that was visually reminiscent of the
experimental situation. Experimentally we observe that most cells seem to engraft
following initial seeding, at least for a while, so the cells in the model were each given a
95% chance of engrafting with the remaining cells being eliminated. The model was then
run for 80 time steps using two different behavioral rules sets corresponding to
computational Hypotheses 1 and 2. Each cell executes its set of commands once within

Figure 49: Schematic of the algorithm used with specific rule sets at each time point to implement
Hypothesis 1 and Hypothesis 2 in the model
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each time step, allowing it to potentially move to a neighboring patch, engraft to a patch,
and/or undergo one round of proliferation. We ran the model for a total of 80 time steps
because most of the cells in the model under both hypotheses had died by this time point,
which

matches

what

we

observed

experimentally

(see

below).

We show a schematic for the general behavior of the models in Figure 49. The
specifics of the model using the rule set for Hypothesis 1 are as follows:
1.

First, the motile cells determine where to move across all three axes. While each cell
has 26 neighbors surrounding it (Fig 48) and there are numerous ways of modeling
how it could move and the number of neighboring patches it could consider moving
to, cell movement in NetLogo is modeled as a forward vector oriented randomly in
some direction relative to the x, y and z axes, thus enabling the cells to explore their
3D environment by moving and considering neighbors in a 2-D fashion along the
direction of the forward vector. The angle of the vector is randomly changed at each
time step, changing the cell’s orientation to the x, y and z axes, unless the cell senses
a high substrate signal in one of the three patches ahead of its current direction
(directly ahead, ahead to the left and ahead to the right), in which case the cell has a
higher chance of moving toward the patch with the strongest signal. (Because of the
angle orientation, these three patches may be above or below the cell’s current
location.) To simulate this in our model, the numerical variables representing
concentrations of substrate, c, on these three patches are each multiplied by a
random number, xi, uniformly distributed on the interval [0, 1], that represents the
likelihoods

of

moving

in

each
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of

the

directions.

If

S = ( x1cahead −and − straight + x 2 cahead −and −left + x3 cahead − and −right ) > 1 , the cell moves towards

the patch with the strongest signal, meaning that all cell movement in the model is
probabilistic. If S < 1, the cell moves randomly to an adjacent patch. (The
concentration of substrate on the current patch is cpatch.) The rules governing cell
movement are based on previous models regarding cellular movement throughout
the lung in the presence and absence of chemical stimuli [9, 10].
2.

All motile cells then determine whether they will attach to the patch they are
currently on. A random real number, N, uniformly distributed on the arbitrary
interval [0, 100] is computed. If N > Ncrit, where Ncrit = 5, the cell is replaced by an
immobile engrafted cell. Each engrafted cell has two parameters: Tlife, the lifespan of
the cell, and Tprol, the amount of time that must pass before the cell can proliferate
into neighboring patches. Upon initially engrafting, Tlife is chosen randomly on the
uniformly distributed interval of [0, 36] time steps, and Tprol is set on the uniform
interval [33, 87]. (This enables some cells to undergo apoptosis before having the
opportunity to proliferate, and to have an increased likelihood of proliferating if the
patch environment enables them to proliferate in a shorter amount of time.)

3.

The lifetime counter, Nlife, for the cell is incremented by 1. If Nlife = Tlife the cell is
eliminated from the model, representing cellular apoptosis.

4.

The proliferation time counter, Nprol, for the cell is incremented by 1. If Nprol = Tprol
the cell places a copy of itself onto a single randomly selected neighbor that has at
most 6 neighbors itself. (The number of neighbors is arbitrarily chosen, but is based
on observations from our experimental images that cells that survive over time are
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surrounded by a small number of cellular neighbors. This suggests that cells require
some moderate degree of cell-cell interaction to thrive.) For each new cell, Tlife is
chosen randomly on the interval [0, 18] time steps, and Tprol is set to (33 - cpatch/
cenvfactor) + n, where cenvfactor = 1.9 and n is a random number uniformly distributed on
the interval [0, 54].
5.

As long as an engrafted cell remains alive, cpatch is increased by camount. This implies
that the engrafted cell through its actions, either directly or indirectly, permanently
increases the concentration of substrate on the patch by camount. If the cell dies, then it
is no longer able to maintain the substrate concentration at this level, so cpatch is
decreased by camount. In our model, camount is set to 1.
Under the rule set for Hypothesis 1, engrafted cells have an equal probability of

surviving anywhere in the environment, but a higher likelihood of proliferating on
patches with higher concentrations of substrate. The rule set for Hypothesis 2 is identical
to Hypothesis 1, with the exceptions that Tlife is distributed uniformly on the interval [0,
45] and Tprol is set on the uniform interval [41, 103], and that for each new cell created,
Tlife is set to (cpatch / cenvfactor) + n, where cenvfactor = 1.9, n is a random number uniformly
distributed on the interval [0, 45], and Tprol is chosen randomly on the uniformly
distributed interval [41, 103] time steps. Under this hypothesis, cells live longer relative
to the cells in Hypothesis 1, and engrafted cells have a higher likelihood of surviving on
patches with higher concentrations of substrate.
6.2.2. Experimental Data
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Cells were seeded onto lung scaffolds from mice as described in Bonenfant et al.
and Wallis et al. [13, 14]. Briefly, the study utilized adult C57BL/6J mice that were
maintained at UVM in accordance with institutional and American Association for
Accreditation of Laboratory Animal Care standards and review. Following heart-lung
bloc harvest, lungs were decellularized under sterile conditions by tracheal and vascular
infusion and immersion in 0.1% Triton-X solution for 24 hours and 2% sodium
deoxycholate for a further 24 hours. Between each incubation step, lungs were rinsed
with 5X penicillin/streptomycin (P/S) in deionized water. On day three, lungs were
incubated for one hour each in 1M NaCl and porcine pancreatic DNase solution. Lungs
were then rinsed with 1x PBS in 1x P/S. The left lobe of decellularized scaffolds was
then inoculated through the airway with either 1x106 mesenchymal stem cells (MSCs)
isolated from mouse bone marrow (Sca-1+, CD106+, CD29+ and CD11b-, CD11c-,
CD34-, and CD45-, from Dr. Darwin Prockop, NCRR/NIH Center for Preparation and
Distribution of Adult Stem Cells at Texas A and M University) [16], or 1x106 C10 mouse
lung epithelial cells (gift from Dr. Matthew Poynter, University of Vermont). Cells were
suspended in 3% low melting point agarose (SeaPrep Agarose, Cambrex) for inoculation.
The inoculated lungs were then allowed to gel at +4°C for 30 minutes and manually
sliced to sections of approximately 1mm thickness. Slices were then incubated at 37°C in
respective growth media in order to remove the agarose. mMSCs (P6-P8) and slices
inoculated with mMSCs were cultured in Iscove’s Modification of Dulbecco’s Medium
supplemented with 2 mM L-glutamine, 100 U/mL penicillin and 100 mg/mL
streptomycin (Fisher), 10% fetal bovine serum (Atlanta Biologicals) and 10% horse
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serum (Invitrogen). C10 cells and slices inoculated with C10 cells were cultured in
DMEM medium supplemented with 2 mM glutamine, penicillin/streptomycin, and 10%
FCS. Media was changed every other day and individual slices were incubated at 37°C at
5% CO2 in low adherence 12 well tissue culture plates. Scaffolds were harvested at days
1, 3, 7, 14, 21 and 28 after inoculation and fixed in 4% paraformaldehyde. Slices were
then embedded in paraffin and sliced to 5µm thick slices, deparaffinized, and stained with
hematoxylin and eosin (H&E).
6.2.3. Image Analysis
Images were taken from the top, middle and bottom of each experimental lung
slice using an Olympus fluorescent microscope at 10x magnification. At each time point
we imaged three slices, for a total of nine experimental images per time point. In our
computational analysis, we took 30 screenshots of 2D slices from the 3D computational
model scaffold every 10 time steps. We defined our model as having a total time duration
evenly divided into 80 time steps. The time scale in this model is arbitrarily defined, but
we can nevertheless map the speed of movement of a model cell from patch to patch onto
the actual speed of movement of real cells, as follows. A model tissue slice consists of 32
x 32 patches corresponding to an area of lung scaffold roughly 1,000 µm x 1,000 µm, so
each model patch has dimensions roughly 30 µm x 30 µm. As 80 time steps in the model
correspond to 28 days of real time, a cell moving from patch to patch at each time step
has a velocity of 0.002 time step/min, corresponding to an actual velocity of about 0.06

175

µ/min. This is of the same order of magnitude as we estimate the velocity of movement
of cells engrafted to lung scaffolds (unpublished observations).
We quantified the patterns of cellular adherence in the images from both the
experimental lung scaffolds and the agent-based model using a custom designed image
analysis tool written in Matlab (Mathworks, Natick, MA), identifies cell nuclei and
divides the image into tiles centered on them by implementing the following algorithm.

Figure 50: Illustration of the image analysis procedure used to define cell neighborhoods using
Voronoi tessellation
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(The Matlab code is available upon request from the authors.) A schematic of this
algorithm is shown in Figure 50, and the details are as follows.
1. Convert the color image to grayscale.
2. Create a black and white version of the grayscale image using a pixel intensity
threshold of 125 on an 8-bit scale from 0 (black) to 255 (white). Identify
contiguous components of at least 300 pixels (considered to be a mixture of
cellular clumps and debris) from the black and white image, which becomes the
image’s “mask” regions.
3. Convert the original grayscale image to a black and white image using a pixel
intensity threshold value of 125. Outside the “mask” regions determined in Step 2,
mark the centroids of all connected components of at most 20 pixels (likely to be
cell nuclei).
4. Repeat Step 3, but with a pixel intensity threshold value of 85, and instead mark
centroids within the “mask” regions.
5. Allow user to manually edit cell identification by including missed cells and
deleting inappropriately included objects.
6. Count the total number of cells in the image by counting the number of cell
nuclei.

177

A

B

C

Figure 51: Experimental image (A), which is processed to mark all cells with crosses for
counting (B) and then undergoes Voronoi tessellation to split the region into tiles centered
around each cell (C)
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7. Apply Voronoi tessellation [17, 18] such that each cell nucleus lies at the centroid
of a polygon-shaped tile that defines the local neighborhood of that cell.
8. Calculate variance of the histogram of Voronoi tile areas.
Figure 51 shows an example of the image processing algorithm applied to an image of a
slice from one of these experimental lung scaffolds, illustrating how the Voronoi
tessellation defines the neighborhood of each cell. In particular, note that the areas of the
6.2.4. Statistical Analysis
The results of the cell culture experiments (C10 cells vs. MSCs) and the

Figure 52: Experimental images of decellularized lung scaffolds at days 1, 3, 7, 14, 21 and 28,
following seeding with C10 epithelial cells (left) and MSCs (right)
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tiles around isolated cells are larger than those around cells which are clustered.
computational modeling (Hypothesis 1 vs. Hypothesis 2) were compared by two-way
ANOVA. Statistical significance was taken as p < 0.05. The sensitivity of model
predictions to variations in model parameter values was assessed by one-way ANOVA.

6.3. Results
Sample images of the decellularized scaffolds at various time points following seeding
with C10s or MSCs show evolving patterns of cellular engraftment and proliferation
across these scaffolds, (Figure 52). We applied our image analysis tool to the 54 images
(at 6 time points taken from 9 separate scaffold images) acquired over the 28 day time
course with the two experimental cell types. Figure 53A shows the number of cells (mean
± SE) from the 9 scaffold images versus time after inoculation, where the results from
each scaffold have been normalized to their respective values on Day 1. Both
C10 and MSC cell numbers eventually approach zero, but at different rates and were
statistically significantly different (p < 0.001). Specifically, the MSC’s have fallen off
markedly by about day 7 whereas the C10 cells take about twice as long to reach
correspondingly low numbers. It should be noted that both cell types eventually die out
completely, meaning that attempts to engraft the scaffold with persistent cells (i.e. cells
that survive and remain engrafted throughout the time course of the experiment) were
ultimately unsuccessful. This speaks to the inherent difficulties of tissue regeneration in
general, and the fact that in the case of the lung this field is still in its infancy.
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Cell numbers and CVHV are expressed as percentages of their respective values
at the initial time point. At the first time point the MSC cell number was 343.33 ± 60.27
and CVHV was 2.93 ± 5.26 x 105, while the C10 cell number was 692.44 ± 111.82 and

Figure 53: Experimental results (Mean ± SE) for (A) number of cells, and (B) CVHV for cells
following the rules for MSCs (open circles) and C10 epithelial cells (closed circles) for all nine images
gathered at days 1, 3, 7, 14, 21 and 28
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CVHV was 2.07 ± 8.84 x 109.
We also determined the variance of the histogram of the Voronoi tile areas at each
time point. This variance gives a measure of the heterogeneity of cell clustering, but
images with greater numbers of cells inherently have smaller variance values compared
to images with fewer cells because more cells means a smaller mean area per cell. To
control for this, we multiplied the histogram variance by the number of cells in the image

Figure 54: Representative screenshots of a computational model of a 3D lung scaffold at 10, 20, 30,
40, 50, 60, 70 and 80 time steps, following seeding with cells that behave according to (left)
Hypothesis 1 (shorter-lived cells with preferential proliferation on areas of higher substrate) and
(right) Hypothesis 2 (longer-lived cells with preferential survival on areas of higher substrate)
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to derive what we term the Corrected Voronoi Histogram Variance (CVHV). Figure 53B
shows that CVHV (mean ± SE, with the results from each scaffold normalized to their
respective values on Day 1) versus time for the two cell types begins to diverge at about
day 14, and is markedly different by the end of the experiment. The CVHV values for the
two cell types were statistically significantly different (p = 0.0064).
We performed a corresponding procedure on images generated by the agent-based
model, where 80 time steps in the model corresponds roughly to 30 days of experimental
time as judged by the relative numbers of surviving cells at the these respective time
points. Patterns of cellular proliferation and spreading throughout a simulated 2D slice of
scaffold created by the agent-based model using the cellular rules specified by
Hypotheses 1 and 2 are shown in Figure 54. Similar numbers of cells initially engraft to
the scaffold in both cases, and as time progresses our image analysis tool enables us to
quantify distinctions between the two hypotheses. While we observed a particularly rapid
drop off for both models around 20 time points, we also observed a faster drop off of cell
numbers in the model for Hypothesis 1 (increased proliferation on higher agent), as seen
in Figure 55A, which shows mean ± SE cell number at each time point determined from
30 independent runs of the model with the results from each run normalized to its
respective Day 1 value. The cell numbers were statistically significantly different for
Hypothesis 1 vs. Hypothesis 2 (p < 0.001). Figure 55B shows the corresponding trends in
CVHV at each time point. Under Hypothesis 1 (shorter lived cells with increased
proliferation on higher local substrate concentration), this value initially rises until 40
time points, and then trends continually downward. Under Hypothesis 2 (longer lived
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cells with increased survival on higher local substrate concentration), this value rises until
50 time points, and its values remain high relative to the initial CVHV values. The
CVHV values under Hypothesis 1 vs. Hypothesis 2 were statistically significantly

Figure 55: Computational model results (Mean ± SE) for (A) number of cells, and (B) CVHV for cells
following the rules for Hypothesis 1 (open circles) and Hypothesis 2 (closed circles) for all 30 images
of 2-D slices gathered from the 3D model at time points 10, 20, 30, 40, 50, 60, 70 and 80
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different (p < 0.001). For both figures, as with the experimental cell numbers and
corrected Voronoi centroids, we have normalized the values by the value observed at the
first time point to focus in the trends.)

Figure 56: Sensitivity analysis of the model parameters expressed in terms of CVHV following (A)
Hypothesis 1 measured at time point 40, and (B) Hypothesis 2 measured at time point 50
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Cell numbers and CVHV are expressed as percentages of their respective values
at the initial time point. At time point 10 under Hypothesis 1 there were 568.90 ± 4.24
engrafted cells with a CVHV value of 3.62 ± 14 x 103, while for Hypothesis 2 there were
596.73 ± 4.76 engrafted cells with a CVHV value of 3.03 ± 0.09 x 103. The sudden
apparent increase in SE at time point 40 is due to the very low cell numbers at this point
and beyond.
We show a sensitivity analysis in Figure 56 for the key parameters of the model
under each of the two hypotheses, determined by increasing or decreasing each parameter
in turn by 5 percent at the beginning of the simulation, and then measuring CVHV (see
figure legend for details). We measure these values at time point 40 for Hypothesis 1 and
time point 50 for Hypothesis 2, as these are time points at which we judged a dramatic
drop in the number of engrafted cells in the original model as these are time points by
which the initial cells must have engrafted and then proliferated or else have died, and
thus variation to the model could theoretically have significant effects on its behavior.
One-way ANOVA indicates that altering Tlife and Tprol results in statistically significant
changes to CVHV for the model under both Hypotheses, which is perhaps not
surprisingly given that these are the two key parameters differentiating cellular behavior
between the two Hypotheses. Altering the other parameters resulted in statistically
insignificant changes to the CVHV value for either of the two Hypotheses.
The original CVHV value is shown at the far left. A, B, C, D and E show CVHV
after increasing (+) and decreasing (-) the attachment probability (Ncrit), the amount of
collagen each cell adds to the environment (camount), the factor by which the cell lifetimes
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or proliferation times are influenced by the environment (cenvfactor), the lifetime (Tlife) and
the proliferation time (Tprol), respectively, by 5%. NS indicates no significant change
from control. * indicates statistically significant change from control.

6.4. Discussion
Stem cell research in the lung has gained considerable momentum recently with
the advent of procedures for recellularizing decellularized lung scaffolds. Nevertheless,
this research remains largely empirical with few predictive tools available to guide
experimentation. As a start to filling this void we have developed a computational model
for testing hypotheses about the rules that might govern cellular engraftment and
proliferation on decellularized lung scaffolds. However, given the number and
complexity of the cellular decisions that can potentially be made during this process,
there is the potential for the number of plausible hypotheses to become so numerous that
no one hypothesis can be supported by model predictions to the exclusion of all the
others. Accordingly, in the present study we apply the model to a very simple
experimental scenario about which the rules of cell behavior appear to be limited to local
environmental factors, such as geometry and chemistry, determining the probabilities of
engraftment, movement and death. Of course, this model is far from a completely
accurate representation of the underlying physiology due to our current lack of
knowledge about all the biological details, about which we are forced to make numerous
assumptions. Once these assumptions are made we can calibrate the time scale of the
model to actual time (e.g. the time scales of Fig 54 relative to Fig 52). Our intent here is
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merely to capture what we believe to be the key aspects of real biological behavior in
order to create a model that has useful predictive value in terms of the overall behavior of
stem cell engraftment on lung scaffolds.
Both C10 cells and MSCs experience a progressive decline in cell numbers over
the time course of the experiment (Fig 52A), so this observation alone does not suggest
anything to distinguish the rules governing the behaviors of these two cells. Indeed, the
almost complete disappearance of both cell types by the end of the 28 day suggests that
the slice culture technique utilized in the present study may be insufficient to support
appropriate long term recellularization, highlighting the need for continued investigation
of alternative recellularization protocols and procedures. On the other hand, visual
inspection of the way in which experimental cell distributions change suggested that there
may be differences in the rules of behavior between the two cell types. These
distributions suggest that the periphery of a slice of scaffold provides a different cellular
environment compared to the scaffold center. We encode this environmental factor in the
model by imposing a gradient in the concentration of a generic substrate that the cells are
sensitive to, and thus that has the potential to cause the cells to make decisions that are
influenced by their locations on the scaffold.
We codified differing tendencies in Hypothesis 1 versus Hypothesis 2, and then
determined if the computational model would lead to qualitatively similar predictions
based on the rules embodied in these hypotheses. The most straightforward manner in
which to compare experiment to prediction is in terms of relative cell numbers. Although
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having the same overall trends, the MSCs nevertheless decrease in number somewhat
more precipitously than the C10s (Fig 52A). By including a greater tendency of cells to
survive on regions of higher substrate concentration (Hypothesis 1) the model predicted
similar differences in cell numbers (Fig 55A). These differences are difficult to
appreciate simply from visual inspection of the model as time evolves (Fig 51),
demonstrating that quantitative metrics are necessary in order to objectively test these
hypotheses.
Cell numbers alone, however, give no information about the topographical details
of the cell populations on the scaffold, yet these details appear to be critical to what
distinguishes the two cell types. Accordingly, we devised an algorithm for calculating
metrics related to cell topography. We wanted this algorithm to be robust, yet at the same
time to be sensitive to the way in which the cells might be clumped together in groups
versus being spread randomly over the scaffold. We felt that these requirements were best
met by an algorithm that incorporates a spatially integrated measure of the local
neighborhood surrounding each cell. Accordingly, we determined the centroid of the
histogram of cell neighborhood areas, the CVHV (Figs 52B and 54B) because this uses
all the information in the histogram to provide a quantity that is robust to noise. The cell
neighborhoods themselves were determined using Voronoi tessellation, which produces a
plan-filling set of tiles having centroid positions defined by each of the identified cells in
the image, and thus provides an intuitively satisfactory way of defining each cell’s
territory. Nevertheless, the CVHV is still a relatively crude overall reflection of cellular
spatial distribution. There are others we could potentially consider that contain more
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information such as mean distance from some landmark, spatial frequency, or the
distribution of distances between pairs of cells. Such metrics might be necessary to test
hypotheses about cellular behavior that are more detailed than the two we consider in the
present study.
The CVHV reveals a key distinction between the two experimental cell types. The
CVHV values for C10s at later time points remain significantly higher relative to the
initial CVHV values (Fig 52B). This same difference in CVHV was recapitulated in the
model by Hypothesis 2 versus Hypothesis 1 (Fig 54B), supporting the notion that MSCs
are more likely to proliferate on the regions of higher substrate concentration that are
located toward the periphery of the scaffold as predicted by Hypothesis 1, while
conversely the C10s are more inclined to survive on regions of higher substrate
concentration as predicted by Hypothesis 2. These conclusions represent only the very
beginning of an elucidation of the enormously complex set of rules governing how cells
behave in a complex environment such as the decellularized lung scaffold. Nevertheless,
they can now be considered notions that have stood up to the first level of scientific
scrutiny, which provides direction for further mechanistic investigation. For example, we
can now ask what the topographical substrate on the scaffold might be, the mechanisms
by which C10s and MSCs respond to it, and potentially what might be manipulated on a
scaffold to improve the success of recellularization.
Of course, these conclusions and the questions they generate are contingent upon
the limitations of our computational model and of our experiments. Such limitations are
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inevitably considerable given the biological complexities of an actual recellularization
scenario, the current paucity of our knowledge about underlying mechanisms and
biological parameters, and the need to make simplifications and approximations in the
interests of computational tractability. For example, a decellularized scaffold is composed
of a large number of extracellular and residual intracellular proteins and proteoglycans
[13, 19], rather than a single functional substrate distributed as a linear gradient. Also,
because sustained recellularization was ultimately unsuccessful in the experimental
system employed in the present study, we consider here only the very initial events in the
process, namely cellular attachment, movement and proliferation. Eventually the
engrafted cells must differentiate if they are to successfully lead to a regenerated tissue,
so our model will eventually have to incorporate these events into its rule set when
suitable experimental data become available. It is also worth noting that there is still
some degree of heterogeneity in the scaffold following decellularization. Studying
cellular engraftment on homogeneously constructed artificial scaffolds might allow for
more precise delineation of the rules of cellular behavior. On the other hand, the behavior
itself might be fundamentally altered by an artificial environment so determining all the
details of the rule sets required for a realistic agent-based model may eventually require a
combination of both approaches. Our computational model thus represents a first step in
the objective evaluation of sets of rules of cell governing the dynamic behavior of cells
engrafted onto decellularized lung scaffolds. This complements other recent studies on
the use of computational modeling to elucidate cellular behavior such as genetic
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expression in individual stem cells [20, 21], the role of stem cells in tumor development
and metastasis [22, 23], and embryogenesis in the pancreas [24].
In conclusion, we have developed an agent-based computational model of cell
behavior following engraftment onto decellularized lung scaffold environments. The
model suggests that MSCs tend to proliferate on areas of higher local concentrations of
substrate when there is an increasing concentration gradient toward the periphery of the
scaffold, but without affecting lifespan. In contrast, the model suggests that C10s
proliferate uniformly everywhere, but are more likely to survive on areas of higher
substrate concentration. It remains to be seen what the actual mechanisms are behind
these behavioral rules, but they may suggest where to look.
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CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS
In the studies presented in this thesis, agent-based modeling provided critical
insight into the nature and behavior of the system. In all the instances mentioned below,
the elucidated behavior could not have been easily predicted without the aid of
computational simulation, and experimental exploration would have taken much time and
effort.
For the twitch study, our model enabled us to take into account all of the allergic
response’s major cellular players and their most important behaviors with respect to each
other and the environment, and showed that these interactions indeed result in twitch-like
behavior—cycles of inflammation and subsequent repair that are dependent on the
frequency of antigen stimulation. Furthermore, most attempts to change the nature of the
response (such as knocking out key cell types, reducing the amount of chemical signals
released and slowing key cell types) were unsuccessful, as they attenuated the magnitude
of response but did not change the overall shape of the response. One exception of note
was when the lifespan of activated pro-inflammatory cells (assumed to be chiefly
composed of neutrophils and eosinophils) was extended, which resulted in a prolonged
inflammatory response increased in magnitude that did not fully resolve to baseline. This
increase in the inflammatory phase was further exacerbated when combined other
alterations that on their own had not previously changed the response.
These observations fueled our subsequent experiments in mice to concretely test
for implications of the twitch hypothesis to determine its experimental validity. We
confirmed that continual antigen stimulation results in behavior consistent with the notion
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of a twitch response with finite duration, as indicated by the trends in markers such as
GM-CSF, total leukocytes and airway resistance. Furthermore, we found evidence of a
refractory period, as seen in the recall responses in markers such as IL-5, total leukocytes
and airway resistance. While not all of the markers demonstrate these two behaviors,
within the 31 day window of the study we observe an early cytokine phase response that
peaked at 3 days followed by an eosinophilic and lung tissue stiffness response that
peaked at day 14. This was followed by a peak in leukocytes between days 14 and 21,
followed by a late cytokine phase response and an airway resistance response that peaks
at day 21.
For the stem cell study, we used agent-based modeling to create a simple
experimental model of a decellularized lung scaffold environment to test how potential
rules for stem cell behavior affect their seeding and engraftment patterns. We then
matched these patterns against patterns in experimental scaffolds seeded with different
types of progenitor cells, enabling us to generate hypotheses about the behavior for each
progenitor cell type. Here we studied two cell types, C10 alveolar epithelial cells and
mesenchymal stem cells (MSCs), that experience a similar drop in cell numbers
following initial engraftment. By comparing them against engraftment patterns from our
model’s rule sets utilizing a parameter that provides information about the spatial
distribution of these components, we were able to put forward the notion that C10s are
more inclined to survive on regions of higher substrate, while MSCs are more likely to
proliferate on regions of higher substrate.
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Naturally, there are multiple means by which we could now extend these studies,
but we focus on what the results indicate as intriguing avenues of exploration. For the
twitch, our computational experiments in Chapter 4 indicate that the overall twitch
behavior, including whether it is able to resolve to baseline, is determined by the behavior
of what are assumed to be chiefly neutrophils and eosinophils. Though our current model
provides insight into the generalized twitch response, it cannot provide insight into the
precise dynamics of these individual components since they are lumped together into a
single, pro-inflammatory cell type. Thus a natural next step would be to ungroup this
lumped cell type into individual constituents, enabling us to individually account for both
neutrophils and eosinophils and other potentially important cells such as the alveolar
macrophage, which is proposed to have both pro-inflammatory and anti-inflammatory
behavior. We could then test proposed rulesets for their behaviors to determine whether
the dynamics mimic the trends indicated by experimental work in mice, including our
own from Chapter 5.
This importance of pro-inflammatory cells also informed our direction for our
proposed experiments. Within the 31 day window studied, we observed that by day 31
eosinophil levels had dropped but still remained elevated relative to baseline, while
neutrophil levels remain elevated without evidence of a decline. To further understand
the dynamics of these cellular responses in vivo, we could extend the study window to 60
days in order to observe whether both neutrophil and eosinophil levels eventually drop to
baseline, or whether they remain elevated. These dynamics would provide further
indication as to whether the twitch response behaves akin to skeletal muscle in allowing
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individual twitch responses to summate, or whether it is akin to cardiac muscle where
summation cannot occur. Extending the window would also enable us to test whether the
eosinophil component has a refractory period longer than 28 days or whether it lacks
refractory behavior altogether.
For the stem cell work, we have taken the first step in determining behavior for
both C10s and MSCs by proposing potential behavior utilizing our agent-based model. A
logical next step is thus to critically test these notions experimentally by determining how
these cells behave in different environments. Of particular interest is the identity of the
presumed substrate in our model, which we suggest is likely an extracellular matrix
component or oxygen. To explore this further, we could place C10s and MSCs in
artificial environments in vitro, such as a hydrogel with an ECM component such as
fibrinogen or laminin, or gels with oxygen gas gradients across them. We could then
observe the resulting behavior over time and compare it to a 2-D simulation of the
models utilizing the proposed rule sets.
It is worth noting that these studies can be extended to address biomedical
questions in other fields. For the stem cell work, this is perhaps most obvious in the
potential to model other progenitor cell types and scaffold environments for other organs.
For the twitch hypothesis, given its implications regarding the nature of chronic
inflammatory conditions in general, we could extend it to study auto-immune diseases in
other organ environments, where the defect involves the body becoming incorrectly
primed to attack a component in the human body thereby resulting in continual antigen
stimulation. Some of these diseases, such as multiple sclerosis in the central nervous
200

system and ulcerative colitis in the colon, have characteristic wax-and-wane behavior that
may correlate to the cycles of damage and repair predicted by the twitch hypothesis.
Central to all of these studies is the agent-based modeling approach. By allowing
us to take into account our understanding of the spatiotemporal dynamics of the
biological systems involved, including cell-cell and cell-environment interactions, this
form of computational modeling can help more rapidly determine the behavior of the
lung (or any biological system) that might otherwise not be apparent. This enables us to
vet multiple hypotheses prior to experimental work that is comparatively more costly in
terms of time and resources in order to determine more promising avenues of research.
Thus computational modeling, particularly agent-based modeling, has the potential to
rapidly accelerate the rate at which we achieve important biomedical insights regarding
organ structure and function and the underlying nature of pathophysiology of disease.
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